142340-99-6 | Adefovir Dipivoxil

Packsize	Purity	Availability	Price	Discounted Price
1mg	98%	in stock	$15.00	$10.00
10mg	98%	in stock	$18.00	$12.00
250mg	98%	in stock	$25.00	$17.00
1g	98%	in stock	$39.00	$27.00
5g	98%	in stock	$87.00	$61.00
25g	98%	in stock	$277.00	$194.00

Description

• Catalog Number: AD71533
• Chemical Name: Adefovir Dipivoxil
• CAS Number: 142340-99-6
• Molecular Formula: C20H32N5O8P
• Molecular Weight: 501.4705
• MDL Number: MFCD00869897
• SMILES: O=C(C(C)(C)C)OCOP(=O)(OCOC(=O)C(C)(C)C)COCCn1cnc2c1ncnc2N

Computed Properties

• Complexity: 706
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 34
• Hydrogen Bond Acceptor Count: 12
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 15
• XLogP3: 1.8

Literature

• Development of an in vitro renal epithelial disease state model for xenobiotic toxicity testing.

  Toxicology in vitro : an international journal published in association with BIBRA 20151225

• Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing.

  Toxicology in vitro : an international journal published in association with BIBRA 20151225

• Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs.

  Toxicological sciences : an official journal of the Society of Toxicology 20150601

• Interleukin-19 as a translational indicator of renal injury.

  Archives of toxicology 20150101

• Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals.

  International journal of pharmaceutics 20121115

• 2D solid-state NMR analysis of inclusion in drug-cyclodextrin complexes.

  Molecular pharmaceutics 20121105

• Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for entecavir partial responders.

  Digestive diseases and sciences 20121101

• Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation.

  Transplant infectious disease : an official journal of the Transplantation Society 20121001

• A case of adefovir-induced membranous nephropathy related to hepatitis B caused by lamivudine-resistant virus after liver transplant due to Byler's disease.

  Clinical and experimental nephrology 20121001

• Does genotype predict response to treatment in children infected with hepatitis B perinatally?

  Journal of medical virology 20121001

• Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: a 5-year study of patients with hepatitis B with lamivudine resistance.

  Journal of medical virology 20121001

• Specific primer sets used to amplify by PCR the hepatitis B virus overlapping S/Pol region select different viral variants.

  Journal of viral hepatitis 20121001

• Viral response at 6 months is associated with treatment outcome of adefovir add-on therapy for lamivudine-resistance.

  Journal of gastroenterology and hepatology 20120901

• Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir.

  Gastroenterology 20120901

• Prevention and management of drug resistant hepatitis B virus infections.

  Journal of gastroenterology and hepatology 20120901

• Comparison of the antiviral effects of entecavir and adefovir dipivoxil in chronic HBV infection: a randomized control trial.

  Acta gastro-enterologica Belgica 20120901

• Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir.

  Liver international : official journal of the International Association for the Study of the Liver 20120801

• Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy.

  Journal of hepatology 20120801

• Prolonged adefovir therapy associated Fanconi syndrome and interstitial nephritis in hepatitis B.

  Internal medicine journal 20120801

• Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.

  Expert review of gastroenterology & hepatology 20120801

• Safety and efficacy of adefovir therapy for lamivudine-resistant hepatitis B virus infection in renal transplant recipients.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20120801

• Persistence versus reversion of 3TC resistance in HIV-1 determine the rate of emergence of NVP resistance.

  Viruses 20120801

• Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donors.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20120701

• Factors influencing inadequate or suboptimal response to adefovir with or without genotypic resistance.

  Journal of medical virology 20120701

• Current practice of chronic hepatitis B treatment in Southern Italy.

  European journal of internal medicine 20120701

• Effects of 1α,25-dihydroxyvitamin D3 on transport and metabolism of adefovir dipivoxil and its metabolites in Caco-2 cells.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20120614

• Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B.

  Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20120601

• New natural variants of hepatitis B virus among Amerindians from Argentina with mainly occult infections.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20120601

• Efficacy and safety of long-term adefovir dipivoxil therapy in children with chronic hepatitis B infection.

  The Pediatric infectious disease journal 20120601

• Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B.

  Alimentary pharmacology & therapeutics 20120601

• Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infection.

  Journal of viral hepatitis 20120601

• [Influence of adefovir dipivoxil or telbivudine monotherapy on renal function of patients with chronic hepatitis B].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20120601

• Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia.

  The Korean journal of internal medicine 20120601

• Evaluation of a 'home-made' method to determine viral genotype and characterize mutations conferring drug resistance in chronic hepatitis B patients.

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20120601

• Efficacy of entecavir and adefovir combination therapy for patients with lamivudine- and entecavir-resistant chronic hepatitis B.

  Digestive diseases and sciences 20120501

• Safety of long-term nucleos(t)ide treatment in chronic hepatitis B.

  Expert opinion on drug safety 20120501

• Improved efficacy by individualized combination therapy with Peg IFN-a 2a and ADV in HBeAg positive chronic hepatitis B patients.

  Hepato-gastroenterology 20120501

• Hepatitis B virus and HIV infection.

  Seminars in liver disease 20120501

• [The therapeutic effect of Anluohuaxian capsule combined with adefovir dipivoxil on patients with chronic hepatitis B and influence on hepatic histology].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20120501

• Convergence and coevolution of hepatitis B virus drug resistance.

  Nature communications 20120417

• Nephrotoxicity, including acquired Fanconi's syndrome, caused by adefovir dipivoxil - is there a safe dose?

  Journal of clinical pharmacy and therapeutics 20120401

• HBV DNA suppression during entecavir treatment in previously treated children with chronic hepatitis B.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20120401

• Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir.

  Scandinavian journal of gastroenterology 20120401

• Hepatitis B virus variant with the a194t substitution within reverse transcriptase before and under adefovir and tenofovir therapy.

  Clinics and research in hepatology and gastroenterology 20120401

• Ten paths to the discovery of antivirally active nucleoside and nucleotide analogues.

  Nucleosides, nucleotides & nucleic acids 20120401

• [Anti-hepatitis B virus drugs].

  Nihon rinsho. Japanese journal of clinical medicine 20120401

• The clinical and laboratory characteristics of patients with chronic hepatitis B using current or past antiviral therapy in Korea: a multi-center, nation-wide, cross-sectional epidemiologic study.

  Gut and liver 20120401

• [Clinical characteristics and effect of secondary individualized therapy in chronic hepatitis B patients infected with the rtA181 mutation hepatitis B virus].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20120401

• [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].

  Orvosi hetilap 20120311

• Simple scoring system predicting genotypic resistance during rescue therapy for Lamivudine-resistant chronic hepatitis B.

  Journal of clinical gastroenterology 20120301

• Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study.

  Journal of hepatology 20120301

• Potent hepatitis B surface antigen response to treatment of hepatitis-B-e-antigen-positive chronic hepatitis B with α-interferon plus a nucleos(t)ide analog.

  Journal of gastroenterology and hepatology 20120301

• Treatment of chronic hepatitis B with nucleos(t)ide analogues.

  Hepatology research : the official journal of the Japan Society of Hepatology 20120301

• Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20120301

• Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance.

  Journal of medical virology 20120301

• Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis.

  Alimentary pharmacology & therapeutics 20120301

• Transarterial chemoembolization for hepatitis B virus-associated hepatocellular carcinoma: improved survival after concomitant treatment with nucleoside analogues.

  Journal of vascular and interventional radiology : JVIR 20120301

• Synthesis, anti-HBV activity and renal cell toxicity evaluation of mixed phosphonate prodrugs of adefovir.

  European journal of medicinal chemistry 20120301

• Bis[(2,2-dimethyl-propano-yloxy)meth-yl] {[2-(6-amino-9H-purin-9-yl)eth-oxy]meth-yl}phospho-nate-succinic acid (2/1).

  Acta crystallographica. Section E, Structure reports online 20120301

• TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.

  PLoS pathogens 20120301

• Revision and update on clinical practice guideline for liver cirrhosis.

  The Korean journal of hepatology 20120301

• High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B.

  The Korean journal of hepatology 20120301

• Therapy for HBV Infection in Hemodialysis Patients: Is it Possible?

  Hepatitis monthly 20120301

• Hepatitis B immune globulin in liver transplantation prophylaxis: an update.

  Hepatitis monthly 20120301

• [Experimental study on effect of dahuang zhechong wan combined with adefovir dipivoxil in preventing hepatic fibrosis in patients with chronic hepatitis B].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20120301

• Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.

  World journal of gastroenterology 20120227

• Synthesis, characterization and biological activity of a niobium-substituted-heteropolytungstate on hepatitis B virus.

  Bioorganic & medicinal chemistry letters 20120215

• Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients.

  Journal of gastroenterology and hepatology 20120201

• rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy.

  Journal of gastroenterology and hepatology 20120201

• In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions.

  Pharmaceutical research 20120201

• High dose lamivudine in HBV-related cirrhotic patients with unsatisfactory response after adefovir add-on.

  Digestive diseases and sciences 20120201

• Molecular characterization of a novel entecavir mutation pattern isolated from a multi-drug refractory patient with chronic hepatitis B infection.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20120201

• A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients with stringent cessation criteria for adefovir.

  Archives of virology 20120201

• The influence of YMDD mutation patterns on clinical outcomes in patients with adefovir add-on lamivudine combination treatment.

  Liver international : official journal of the International Association for the Study of the Liver 20120201

• Differential effects of acyclic nucleoside phosphonates on nitric oxide and cytokines in rat hepatocytes and macrophages.

  International immunopharmacology 20120201

• Adefovir dipivoxil in chronic hepatitis B: history and current uses.

  Expert opinion on pharmacotherapy 20120201

• Diagnostic incidence of the presence of positive HBsAg: epidemiologic, clinical, and virological characteristics.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20120201

• [Research on molecular mechanism of drug resistance of adefovir dipivoxil].

  Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20120201

• [Efficacy of lamivudine and adefovir de novo combination therapy or after mono-therapy in chronic hepatitis B patients].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20120201

• Hepatitis B virus genotype G infection in a Turkish patient undergoing hemodialysis therapy.

  Hepatitis monthly 20120201

• [Clinical study on Baihua Xianglian detoxification recipe combined with adefovir dipivoxil in treating HBeAg positive chronic hepatitis].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20120201

• Polymorphic and kinetic investigation of adefovir dipivoxil during phase transformation.

  International journal of pharmaceutics 20120117

• Presteady state kinetic investigation of the incorporation of anti-hepatitis B nucleotide analogues catalyzed by noncanonical human DNA polymerases.

  Chemical research in toxicology 20120113

• An improved reverse dot hybridization for simple and rapid detection of adefovir dipivoxil-resistant hepatitis B virus.

  Genetics and molecular research : GMR 20120109

• Antiviral drug resistance testing in patients with chronic hepatitis B.

  Digestive diseases and sciences 20120101

• Adefovir dipivoxil modulates cytokine expression in Th1/Th2 cells in patients with chronic hepatitis B.

  Molecular medicine reports 20120101

• Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B.

  Journal of medical virology 20120101

• Five years of treatment with adefovir dipivoxil in Chinese patients with HBeAg-positive chronic hepatitis B.

  Liver international : official journal of the International Association for the Study of the Liver 20120101

• In vitro anti-hepatitis B and SARS virus activities of a titanium-substituted-heteropolytungstate.

  Antiviral research 20120101

• Prevalence, virology and antiviral drugs susceptibility of hepatitis B virus rtN238H polymerase mutation from 1865 Chinese patients with chronic hepatitis B.

  Antiviral research 20120101

• Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B.

  International journal of medical sciences 20120101

• Hepatitis B surface gene 145 mutant as a minor population in hepatitis B virus carriers.

  BMC research notes 20120101

• Risk factors of gene-resistant mutations in different nucleosides.

  Hepato-gastroenterology 20120101

• Entecavir plus adefovir combination treatment for chronic hepatitis B patients after failure of nucleoside/nucleotide analogues.

  Antiviral therapy 20120101

• Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV-HBV-coinfected patients with delayed response to tenofovir.

  Antiviral therapy 20120101

• Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment.

  Antiviral therapy 20120101

• HBV DNA level at 24 weeks is the best predictor of virological response to adefovir add-on therapy in patients with lamivudine resistance.

  Antiviral therapy 20120101

• Management of treatment failure in chronic hepatitis B.

  Journal of hepatology 20120101

• High-resolution melting and real-time PCR for quantification and detection of drug-resistant HBV mutants in a single amplicon.

  Antiviral therapy 20120101

• Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C.

  Mediators of inflammation 20120101

• Hepatitis B viral breakthrough associated with inappropriate preservation of entecavir.

  Indian journal of pharmacology 20120101

• Treatment response and evolution of HBV resistance during lamivudine plus adefovir or entecavir therapy in patients with adefovir-resistant mutants.

  Antiviral therapy 20120101

• Large fragment pre-S deletion and high viral load independently predict hepatitis B relapse after liver transplantation.

  PloS one 20120101

• Effectiveness of Chinese herbal medicine in treating liver fibrosis: a systematic review and meta-analysis of randomized controlled trials.

  Chinese medicine 20120101

• Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes.

  PloS one 20120101

• Clinical implications of HBsAg quantification in patients with chronic hepatitis B.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101

• Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis.

  PloS one 20120101

• RNA interference: a promising approach for the treatment of viral hepatitis.

  Hepatitis monthly 20120101

• [Prognosis analysis of hepatitis B virus recurrence after liver transplantation: a single-center study of 38 cases].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20120101

• [Evaluation of the safety of pregnancy initiated by chronic hepatitis B fathers while taking adefovir].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20120101

• Novel therapeutic strategies targeting HIV integrase.

  BMC medicine 20120101

• Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.

  PloS one 20120101

• Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings.

  AIDS research and treatment 20120101

• Efficacy and adverse effects of the antiviral compound plerixafor in feline immunodeficiency virus-infected cats.

  Journal of veterinary internal medicine 20120101

• Effects of telbivudine treatment on the circulating CD4⁺ T-cell subpopulations in chronic hepatitis B patients.

  Mediators of inflammation 20120101

• New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir.

  HIV/AIDS (Auckland, N.Z.) 20120101

• Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.

  PloS one 20120101

• Viral infection in renal transplant recipients.

  TheScientificWorldJournal 20120101

• Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism.

  PloS one 20120101

• Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome.

  PloS one 20120101

• In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations.

  Antiviral therapy 20120101

• Reactivation of hepatitis B virus replication due to cytotoxic therapy: a five-year prospective study.

  Tumori 20120101

• The antiviral drug valacyclovir successfully suppresses salivary gland hypertrophy virus (SGHV) in laboratory colonies of Glossina pallidipes.

  PloS one 20120101

• Anti-hepatitis B virus effect and possible mechanism of action of 3,4-o-dicaffeoylquinic Acid in vitro and in vivo.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Rescue therapy for lamivudine-resistant chronic hepatitis B: adefovir monotherapy, adefovir plus lamivudine or entecavir combination therapy.

  Internal medicine (Tokyo, Japan) 20120101

• Lamivudine plus adefovir or telbivudine plus adefovir for chronic hepatitis B patients with suboptimal response to adefovir.

  Antiviral therapy 20120101

• Comparison of entecavir and adefovir for the treatment of chronic hepatitis B.

  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20120101

• Profile of users of drugs for the treatment of chronic hepatitis B available through the Brazilian Public Health System.

  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20120101

• Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy.

  Antiviral therapy 20120101

• Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report.

  Diagnostic pathology 20120101

• Laboratory evaluation of three regimens of treatment of chronic hepatitis B: tenofovir, entecavir and combination of lamivudine and adefovir.

  Journal of laboratory physicians 20120101

• High frequency of recurrent viremia after hepatitis B e antigen seroconversion and consolidation therapy.

  Journal of clinical gastroenterology 20120101

• Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective.

  ClinicoEconomics and outcomes research : CEOR 20120101

• Management of hepatitis B in developing countries.

  World journal of hepatology 20111227

• Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.

  Drugs 20111224

• Observation of genotype C infected chronic hepatitis B patients in clinical practice.

  Journal of infection in developing countries 20111213

• Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma.

  The Cochrane database of systematic reviews 20111207

• Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects?

  Immunopharmacology and immunotoxicology 20111201

• Adefovir induced hypophosphatemic osteomalacia.

  Scandinavian journal of infectious diseases 20111201

• Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B.

  Journal of hepatology 20111201

• Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B.

  The Journal of antimicrobial chemotherapy 20111201

• Medical management of chronic liver diseases in children (part I): focus on curable or potentially curable diseases.

  Paediatric drugs 20111201

• Cost effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B from a Canadian public payer perspective.

  PharmacoEconomics 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Factors predicting the efficacy of adefovir dipivoxil on treatment-naïve chronic hepatitis B patients at 48 weeks.

  Gut and liver 20111201

• Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients.

  The Korean journal of hepatology 20111201

• Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B.

  The Korean journal of hepatology 20111201

• Effect and Predictive Elements for 52 Weeks' Telbivudine Treatment on Naïve HBeAg positive Chronic Hepatitis B.

  Hepatitis monthly 20111201

• [Optimization and assessment of a reverse hybridization system for the detection of HBV drug-resistant mutations].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20111201

• [The clinical efficacy and safety of adefovir dipivoxil in combination with bicyclol for the treatment of senior patients with chronic hepatitis B].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20111201

• De novo combination therapy with lamivudine and adefovir dipivoxil in chronic hepatitis B patients.

  World journal of gastroenterology 20111121

• Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus (J Viral Hepat 2010 Feb 1;17(2):123-9).

  Journal of viral hepatitis 20111101

• Application of kinase bypass strategies to nucleoside antivirals.

  Antiviral research 20111101

• Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings.

  Journal of medical virology 20111101

• Antiviral activity of novel 2'-fluoro-6'-methylene-carbocyclic adenosine against wild-type and drug-resistant hepatitis B virus mutants.

  Bioorganic & medicinal chemistry letters 20111101

• Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients.

  Liver international : official journal of the International Association for the Study of the Liver 20111101

• [Adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia associated with muscular weakness in a patient with chronic hepatitis B].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111101

• [Entecavir 1.0mg monotherapy or entecavir plus adefovir dipivoxil for patients with lamivudine-resistant chronic hepatitis B had suboptimal response to lamivudine plus adefovir dipivoxil].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20111101

• Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.

  Journal of gastroenterology and hepatology 20111001

• Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20111001

• Hepatitis B virus infection and pregnancy.

  Clinics and research in hepatology and gastroenterology 20111001

• Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.

  Liver international : official journal of the International Association for the Study of the Liver 20111001

• Antiviral drug-associated potential vaccine-escape hepatitis B virus mutants in Turkish patients with chronic hepatitis B.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20111001

• The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir.

  Alimentary pharmacology & therapeutics 20111001

• Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir.

  Alimentary pharmacology & therapeutics 20111001

• Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir.

  Journal of viral hepatitis 20111001

• Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance.

  Journal of viral hepatitis 20111001

• Clinical outcomes of lamivudine-adefovir therapy in chronic hepatitis B cirrhosis.

  Journal of clinical gastroenterology 20111001

• Antiviral drugs for viruses other than human immunodeficiency virus.

  Mayo Clinic proceedings 20111001

• Novel polymorphic form of adefovir dipivoxil derived from polymer-directed crystallization.

  Die Pharmazie 20111001

• Chronic hepatitis B: management challenges in resource-poor countries.

  Hepatitis monthly 20111001

• Frequency and mutation patterns of resistance in patients with chronic hepatitis B infection treated with nucleos(t)ide analogs in add-on and switch strategies.

  Hepatitis monthly 20111001

• [A clinical study on the efficacy of HBeAg-positive chronic hepatitis B patients treated with adefovir dipivoxil for 4 years].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20111001

• Efficacy and pharmacokinetics of adefovir dipivoxil liquid suspension in patients with chronic hepatitis B and renal impairment.

  Journal of clinical pharmacology 20110901

• The cost-effectiveness of alternative strategies against HBV in Italy.

  Health policy (Amsterdam, Netherlands) 20110901

• Evaluation of peptide nucleic acid array for the detection of hepatitis B virus mutations associated with antiviral resistance.

  Archives of virology 20110901

• Drug safety evaluation of adefovir in HBV infection.

  Expert opinion on drug safety 20110901

• Four-year follow-up of two chronic hepatitis B recipients of hepatitis B surface antigen-positive cadaveric liver grafts from asymptomatic carriers.

  Hepatology research : the official journal of the Japan Society of Hepatology 20110901

• Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B.

  Gut and liver 20110901

• Molecular epidemiology of hepatitis B virus.

  The Korean journal of internal medicine 20110901

• The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shock.

  Toxins 20110901

• [Clinical antiviral effects of Peg-IFNa-2a in patients with chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20110901

• [A case of adefovir dipivoxil induced hypophosphataemic osteomalacia and literature review].

  Zhonghua nei ke za zhi 20110901

• Treatment of chronic delta hepatitis.

  Hepatitis monthly 20110901

• Virological response to adefovir monotherapy and the risk of adefovir resistance.

  World journal of gastroenterology 20110814

• A biomimetic chitosan derivates: preparation, characterization and transdermal enhancement studies of N-arginine chitosan.

  Molecules (Basel, Switzerland) 20110809

• Sequential therapy with adefovir dipivoxil and pegylated interferon alfa-2a for HBeAg-negative patients.

  Journal of viral hepatitis 20110801

• Defining virologic relapse in chronic hepatitis B.

  Digestive diseases and sciences 20110801

• Medication nonadherence with long-term management of patients with hepatitis B e antigen-negative chronic hepatitis B.

  Digestive diseases and sciences 20110801

• Development of immunity against hepatitis B virus after donor lymphocyte infusion in a peripheral blood stem cell transplantation recipient with chronic hepatitis B.

  Infection 20110801

• Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy.

  Alimentary pharmacology & therapeutics 20110801

• Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance.

  Alimentary pharmacology & therapeutics 20110801

• Tsetse salivary gland hypertrophy virus: hope or hindrance for tsetse control?

  PLoS neglected tropical diseases 20110801

• [Efficacy of two nucleoside analogs to treat resistant HBeAg-negative chronic hepatitis B].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20110801

• Recent advances in the management of chronic hepatitis B.

  Hepatitis monthly 20110801

• Prevention of hepatitis B recurrence in liver transplant patients using oral antiviral therapy without long-term hepatitis B immunoglobulin.

  Hepatitis monthly 20110801

• Life-threatening hypophosphataemia in a cirrhotic patient with jaundice.

  Archives of medical science : AMS 20110801

• The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond.

  Biochemical pharmacology 20110715

• Add-on adefovir is superior to a switch to entecavir as rescue therapy for Lamivudine-resistant chronic hepatitis B.

  Digestive diseases and sciences 20110701

• Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study.

  Hepatology (Baltimore, Md.) 20110701

• Detection of lamivudine- or adefovir-resistant hepatitis B virus mutations by a liquid array.

  Journal of virological methods 20110701

• Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis B.

  Journal of medical virology 20110701

• Adefovir serum levels do not differ between responders and nonresponders.

  Journal of viral hepatitis 20110701

• Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B.

  Journal of viral hepatitis 20110701

• [Effect of shugan jianpi bushen recipe on splenic T lymphocytes and virus load in hepatitis B virus transgenic mice].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20110701

• Long-term effects of lamivudine treatment in Japanese chronic hepatitis B patients.

  World journal of gastroenterology 20110628

• Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.

  Journal of viral hepatitis 20110601

• Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs.

  Scandinavian journal of gastroenterology 20110601

• De novo combination of lamivudine and adefovir versus entecavir monotherapy for the treatment of naïve HBeAg-negative chronic hepatitis B patients.

  Hepatology international 20110601

• Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance.

  Hepatology international 20110601

• Long-term add-on therapy with adefovir in lamivudine-resistant kidney graft recipients with chronic hepatitis B.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110601

• Clinical course and predictive factors of virological response in long-term lamivudine plus adefovir dipivoxil combination therapy for lamivudine-resistant chronic hepatitis B patients.

  Journal of medical virology 20110601

• New prodrugs of Adefovir and Cidofovir.

  Bioorganic & medicinal chemistry 20110601

• Reviving pegylated interferon as a therapeutic agent for hepatitis D: no more room for nucleos(t)ides?

  Hepatology (Baltimore, Md.) 20110601

• Hepatitis: PEG-IFN for the treatment of hepatitis D.

  Nature reviews. Gastroenterology & hepatology 20110601

• [Safety and efficacy of Entecavir combined with Adefovir in patients with chronic hepatitis B who fail to respond to nucleoside analog treatment].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20110601

• [Relationship between HBeAg seroconversion with genotypes and HBV specific CTL in patients with chronic hepatitis B treated with Adefovir dipivoxil].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20110601

• [Lamivudine-resistant analysis and management for chronic hepatitis B patients with initial lamivudine therapy].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20110601

• [HBV resistance mutants before and after adefovir dipivoxil treatment and the relationship with HBV genotypes].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20110601

• Association of interleukin 18 gene promoter polymorphisms with HBV recurrence after liver transplantation in Han Chinese population.

  Hepatitis monthly 20110601

• [Interferon-based versus direct antiviral therapy in patients with chronic hepatitis B].

  Orvosi hetilap 20110529

• Parallel decline of CD8+CD38+ lymphocytes and viremia in treated hepatitis B patients.

  World journal of gastroenterology 20110507

• HBV DNA replication mediated by cloned patient HBV reverse transcriptase genes from HBV genotypes A-H and its use in antiviral phenotyping assays.

  Journal of virological methods 20110501

• [A case with poly-bone pain, decrease of bone density and in crease of serum creatinine related to adefovir dipivoxil treatment in a chronic hepatitis B patient].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20110501

• The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine.

  Hepatitis monthly 20110501

• [The past, present and future treatment for chronic hepatitis B].

  Nihon rinsho. Japanese journal of clinical medicine 20110501

• [Lamivudine, adefovir dipivoxil].

  Nihon rinsho. Japanese journal of clinical medicine 20110501

• [Prevention for the development of hepatitis B virus-related hepatocellular carcinoma by anti-viral treatment].

  Nihon rinsho. Japanese journal of clinical medicine 20110501

• Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients.

  Transplantation 20110427

• Phyllanthus species for chronic hepatitis B virus infection.

  The Cochrane database of systematic reviews 20110413

• Initial virological response and viral mutation with adefovir dipivoxil added to ongoing Lamivudine therapy in Lamivudine-resistant chronic hepatitis B.

  Digestive diseases and sciences 20110401

• The level of HBV DNA at month 12 is an important predictor of virological breakthrough during adefovir monotherapy in chronic hepatitis B patients with lamivudine resistance.

  Digestive diseases and sciences 20110401

• Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6).

  Biochemical pharmacology 20110401

• Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents.

  Journal of medical virology 20110401

• Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection.

  Journal of viral hepatitis 20110401

• Enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation.

  The Journal of pharmacy and pharmacology 20110401

• Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20110401

• Modeling of autocatalytic hydrolysis of adefovir dipivoxil in solid formulations.

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110401

• Precore and core promoter mutations of the hepatitis B virus gene in chronic genotype C-infected children.

  Journal of Korean medical science 20110401

• [Progress and perspectives in treatment of chronic hepatitis B].

  Nihon rinsho. Japanese journal of clinical medicine 20110401

• [Improvement of health-related quality of life in chronic hepatitis B patients treated with entecavir or adefovir].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20110401

• [One-year combination therapy de novo of adefovir dipivoxil and lamivudine for decompensated cirrhosis related to HBV].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20110401

• [The levels of HBsAg can predict the efficacy of peglated interferon-alpha 2a combined with adefovir dipivoxil, in HBeAg-positive chronic hepatitis B patients].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20110401

• Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern.

  Journal of viral hepatitis 20110301

• Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment.

  Journal of general internal medicine 20110301

• Systematic review of the literature on comparative effectiveness of antiviral treatments for chronic hepatitis B infection.

  Journal of general internal medicine 20110301

• Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model.

  American journal of physiology. Heart and circulatory physiology 20110301

• 1α,25-dihydroxyvitamin D3 on intestinal transporter function: studies with the rat everted intestinal sac.

  Biopharmaceutics & drug disposition 20110301

• No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus.

  Hepatology (Baltimore, Md.) 20110301

• Chronic hepatitis B in pregnancy: unique challenges and opportunities.

  The Korean journal of hepatology 20110301

• Chronic hepatitis B: integrating long-term treatment data and strategies to improve outcomes in clinical practice.

  Gastroenterology & hepatology 20110301

• Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy.

  British journal of cancer 20110215

• Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B.

  Gut 20110201

• Characteristics of adefovir resistance in patients with or without lamivudine-resistant hepatitis B virus treated with adefovir: a 4-year experience.

  Liver international : official journal of the International Association for the Study of the Liver 20110201

• [Treatment of patients with lamivudine-resistant chronic hepatitis B].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110201

• [Efficacy of entecavir and adefovir combination therapy in patients with chronic hepatitis B refractory to lamivudine and adefovir combination therapy].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110201

• [Virological response to adefovir dipivoxil predicts the long-term development of resistance in previously untreated patients with HBeAg-negative chronic hepatitis B].

  Gastroenterologia y hepatologia 20110201

• Adefovir-induced Stevens-Johnson syndrome and toxic epidermal necrolysis overlap syndrome.

  Singapore medical journal 20110201

• [The replication capacity and drug sensitivity of Adefovir dipivoxil-resistant HBV mutants in vivo].

  Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20110201

• Peginterferon plus adefovir versus either drug alone for hepatitis delta.

  The New England journal of medicine 20110127

• Hypophosphatemic osteomalacia as a long-term complication after liver transplantation.

  Transplantation 20110115

• Long-term outcome of patients with lamivudine after early cessation of hepatitis B immunoglobulin for prevention of recurrent hepatitis B following liver transplantation.

  Clinical transplantation 20110101

• Hypophosphataemic osteomalacia in patients on adefovir dipivoxil.

  Journal of clinical gastroenterology 20110101

• Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B.

  Journal of hepatology 20110101

• Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies.

  Cellular & molecular immunology 20110101

• Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

  Gastroenterology 20110101

• Characterization of hepatitis virus B isolated from a multi-drug refractory patient.

  Virus research 20110101

• Treatment of chronic hepatitis B: Evolution over two decades.

  Journal of gastroenterology and hepatology 20110101

• Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues.

  Liver international : official journal of the International Association for the Study of the Liver 20110101

• Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues.

  Liver international : official journal of the International Association for the Study of the Liver 20110101

• Hepatitis B virus resistance to antiviral drugs: where are we going?

  Liver international : official journal of the International Association for the Study of the Liver 20110101

• The impact of human immunodeficiency virus on viral hepatitis.

  Liver international : official journal of the International Association for the Study of the Liver 20110101

• An overview of treatment response rates to various anti-viral drugs in Pakistani hepatitis B virus infected patients.

  Virology journal 20110101

• Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function.

  PloS one 20110101

• Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.

  Hepatology (Baltimore, Md.) 20110101

• Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study.

  BMC public health 20110101

• HBV core region variability: effect of antiviral treatments on main epitopic regions.

  Antiviral therapy 20110101

• Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B.

  Antiviral therapy 20110101

• Management of chronic hepatitis B patients: efficacy & limitation of nucleos(t)ide analogues.

  The Indian journal of medical research 20110101

• Evaluation of adefovir & lamivudine in chronic hepatitis B: correlation with HBV viral kinetic, hepatic-necro inflammation & fibrosis.

  The Indian journal of medical research 20110101

• Long-term nucleos(t)ide analogues therapy for adults with chronic hepatitis B reduces the risk of long-term complications: a meta-analysis.

  Virology journal 20110101

• Expression of Hepatitis B Virus Surface Antigen Containing Y100C Variant Frequently Detected in Occult HBV Infection.

  Hepatitis research and treatment 20110101

• Comparison of the 48-week efficacy between entecavir and adefovir in HBeAg-positive nucleos(t)ide-naïve Asian patients with chronic hepatitis B: a meta-analysis.

  Virology journal 20110101

• Antiproliferative property of hexadecyloxypropyl 9-[2-(phosphonomethoxy) ethyl] guanine (HDP-PMEG) for unwanted ocular proliferation.

  Molecular vision 20110101

• Comparison of the efficacy of tenofovir and adefovir in the treatment of chronic hepatitis B: a systematic review.

  Virology journal 20110101

• On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients.

  Antiviral therapy 20110101

• [Treatment of chronic hepatitis B].

  La Revue du praticien 20110101

• [Current treatment of hepatitis B infection: where do the new nucleos(t)ide analogues fit in?].

  Gastroenterologia y hepatologia 20110101

• Multiplex fluorescence melting curve analysis for mutation detection with dual-labeled, self-quenched probes.

  PloS one 20110101

• Two patterns of alanine aminotransferase increase to predict long-term viral response in chronic hepatitis B patients: virus- or host-induced?

  Antiviral therapy 20110101

• Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis.

  BMC pediatrics 20110101

• Probing rate of YMDD motif mutant in lamivudine treatment of Iranian patients with chronic hepatitis B virus infection.

  Asian journal of transfusion science 20110101

• Severe acute hepatitis B treated with entecavir.

  Mediterranean journal of hematology and infectious diseases 20110101

• Development and validation of an LC/MS/MS method for the determination of tenofovir in monkey plasma.

  Biological & pharmaceutical bulletin 20110101

• Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials.

  BMC infectious diseases 20110101

• Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipient.

  Annals of hepatology 20110101

• Changes of serum levels of keratin-18 fragments in hepatitis B e antigen-negative chronic hepatitis B patients under oral antiviral therapy.

  Antiviral therapy 20110101

• Safety and efficacy of entecavir for the treatment of chronic hepatitis B.

  Infection and drug resistance 20110101

• Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.

  PloS one 20110101

• Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations.

  BMC infectious diseases 20110101

• Tenofovir nephrotoxicity: 2011 update.

  AIDS research and treatment 20110101

• High frequency of CD4+ CXCR5+ TFH cells in patients with immune-active chronic hepatitis B.

  PloS one 20110101

• Effects of HBV Genetic Variability on RNAi Strategies.

  Hepatitis research and treatment 20110101

• High rate of complete viral suppression with combination therapy in patients with chronic hepatitis B and prior treatment failure.

  Journal of clinical gastroenterology 20110101

• [Reactivation of hepatitis B in a patient with spondyloarthritis after the suspension of methotrexate and efficacy of treatment with antivirals in association to adalimumab].

  Reumatologia clinica 20110101

• Interferon impedes an early step of hepatitis delta virus infection.

  PloS one 20110101

• The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity.

  PloS one 20110101

• Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment.

  Virology journal 20110101

• Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding.

  Antiviral therapy 20110101

• Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis.

  Virology journal 20110101

• Nephrotoxicity of HAART.

  AIDS research and treatment 20110101

• Evolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B.

  Annals of hepatology 20110101

• Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil.

  BMC infectious diseases 20110101

• Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B.

  BMC cancer 20110101

• A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy.

  ClinicoEconomics and outcomes research : CEOR 20110101

• Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-year prospective study.

  Virology journal 20110101

• Clinical impact of the development of YMDD mutants in hepatitis B virus-associated glomerulonephritis.

  Hepato-gastroenterology 20110101

• Anti-viral therapy in chronic HBV infection: a single centre experience.

  Hepato-gastroenterology 20110101

• Evaluation of intra-host variants of the entire hepatitis B virus genome.

  PloS one 20110101

• Rapid high-performance liquid chromatographic method for determination of adefovir in plasma using UV detection: application to pharmacokinetic studies.

  Arzneimittel-Forschung 20110101

• Virologic and clinical characteristics of HBV genotypes/subgenotypes in 487 Chinese pediatric patients with CHB.

  BMC infectious diseases 20110101

• Enrollment characteristics and risk behaviors of injection drug users participating in the Bangkok Tenofovir Study, Thailand.

  PloS one 20110101

• Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients.

  ISRN gastroenterology 20110101

• The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma.

  International journal of hepatology 20110101

• Treatment of hepatitis B in decompensated liver cirrhosis.

  International journal of hepatology 20110101

• A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel.

  PloS one 20110101

• Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.

  PloS one 20110101

• A comparison of treatment with adefovir and entecavir for chronic hepatitis B in China: The 2-year results of a prospective study: Adefovir versus Entercavir for Chronic Hepatitis B.

  Hepatitis monthly 20110101

• Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation.

  PloS one 20110101

• NDRG2 ameliorates hepatic fibrosis by inhibiting the TGF-β1/Smad pathway and altering the MMP2/TIMP2 ratio in rats.

  PloS one 20110101

• Characterization of Abcc4 gene amplification in stepwise-selected mouse J774 macrophages resistant to the topoisomerase II inhibitor ciprofloxacin.

  PloS one 20110101

• Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection.

  PloS one 20110101

• Toll-like receptors signaling contributes to immunopathogenesis of HBV infection.

  Gastroenterology research and practice 20110101

• Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa.

  BMC research notes 20110101

• Simultaneous detection of hepatitis B virus genotypes and mutations associated with resistance to lamivudine, adefovir, and telbivudine by the polymerase chain reaction-ligase detection reaction.

  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20110101

• [Polish multicenter study on safety and efficacy of adefovir dipivoxil in the treatment of lamivudine resistant chronic hepatitis B in adults (HEP 2008)].

  Przeglad epidemiologiczny 20110101

• Viral hepatitis: retrospective review in a canadian pediatric hospital.

  ISRN pediatrics 20110101

• Development of osteomalacia in a post-liver transplant patient receiving adefovir dipivoxil.

  World journal of hepatology 20101227

• Simple nucleos(t)ides as HBV prophylaxis regime of post-liver transplantation: Six-year followed up.

  World journal of hepatology 20101227

• Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20101201

• Cost-utility analysis of tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20101201

• Mixed treatment comparison meta-analysis evaluating the relative efficacy of nucleos(t)ides for treatment of nucleos(t)ide-naive patients with chronic hepatitis B.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20101201

• Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery.

  Antiviral research 20101201

• Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options.

  Hepatology (Baltimore, Md.) 20101201

• Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.

  PLoS pathogens 20101201

• Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation.

  Minerva medica 20101201

• [Efficacy of adefovir treatment in the lamivudine-resistant chronic hepatitis B patients].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20101201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20101201

• Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.

  Viruses 20101201

• A low viral load predicts a higher initial virologic response to adefovir in patients with Lamivudine-resistant chronic hepatitis B.

  Gut and liver 20101201

• Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B.

  Hepatology international 20101201

• Cidofovir Activity against Poxvirus Infections.

  Viruses 20101201

• HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.

  Liver international : official journal of the International Association for the Study of the Liver 20101101

• Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B.

  Journal of medical virology 20101101

• High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients.

  European journal of gastroenterology & hepatology 20101101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20101101

• Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection.

  Gastroenterology 20101001

• Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.

  Gastroenterology 20101001

• Telbivudine: a review of its use in compensated chronic hepatitis B.

  Drugs 20101001

• Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.

  Expert review of anti-infective therapy 20101001

• Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature.

  Journal of Crohn's & colitis 20101001

• Post-transplant infections: An ounce of prevention.

  Indian journal of nephrology 20101001

• [Influence of adefovir dipivoxil on HBV specific CTL in patients with chronic hepatitis B].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20101001

• Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100901

• Identification of adenovirus, influenza virus, parainfluenza virus, and respiratory syncytial virus by two kinds of multiplex polymerase chain reaction (PCR) and a shell vial culture in pediatric patients with viral pneumonia.

  Yonsei medical journal 20100901

• Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir.

  Journal of hepatology 20100901

• Question of ALT flare during switch to adefovir from lamivudine: A single center open-label, randomized, safety study (June 17, 2005 to February 5, 2009).

  Journal of medical virology 20100901

• Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses.

  Expert opinion on pharmacotherapy 20100901

• Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner.

  PLoS pathogens 20100901

• Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized study.

  The Korean journal of hepatology 20100901

• Fanconi's Syndrome Associated with Prolonged Adefovir Dipivoxil Therapy in a Hepatitis B Virus Patient.

  Gut and liver 20100901

• [Analogs combination therapy in chronic hepatitis B: when and how?].

  Gastroenterologie clinique et biologique 20100901

• [Long-term therapy for chronic hepatitis B in HIV co-infected patients].

  Gastroenterologie clinique et biologique 20100901

• [Treatment has a positive impact on the long-term evolution of chronic hepatitis B].

  Gastroenterologie clinique et biologique 20100901

• Surgical treatment of HCC in a patient with lamivudine-resistant hepatitis B cirrhosis with adefovir dipivoxil.

  World journal of hepatology 20100827

• Long-term outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments.

  Transplantation 20100815

• Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis.

  Transplant infectious disease : an official journal of the Transplantation Society 20100801

• Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.

  Antimicrobial agents and chemotherapy 20100801

• Cost-effectiveness of nucleoside analog therapy for hepatitis B in China: a Markov analysis.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20100801

• Acute hepatitis B infection associated with drug-resistant hepatitis B virus.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20100801

• Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of adefovir in human plasma and its application to a pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100801

• Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy.

  Journal of gastroenterology and hepatology 20100801

• The curative efficiency of tenofovir for patients with chronic hepatitis B after failure of nucleoside/nucleotide analogues.

  Hepatology (Baltimore, Md.) 20100801

• [Add on lamivudine to adefovir monotherapy for the treatment of lamivudine-resistant chronic hepatitis B patients].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20100801

• [A case of osteomalacia related to adefovir in a patient with chronic hepatitis B].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20100801

• [Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20100801

• [Design, synthesis and anti-hBV evaluation of adefovir mono-L-amino acid ester, mono non-steroidal anti-inflammatory drugs carboxylic ester prodrugs].

  Yao xue xue bao = Acta pharmaceutica Sinica 20100801

• Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report.

  Viruses 20100801

• Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.

  Toxins 20100801

• [Treatment of chronic hepatitis B. High response rate in general practice].

  MMW Fortschritte der Medizin 20100722

• Metal ion-binding properties of 9-[(2-phosphonomethoxy)ethyl]-2-aminopurine (PME2AP), an isomer of the antiviral nucleotide analogue 9-[(2-phosphonomethoxy)ethyl]adenine (PMEA). Steric guiding of metal ion-coordination by the purine-amino group.

  Dalton transactions (Cambridge, England : 2003) 20100721

• Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation.

  The Cochrane database of systematic reviews 20100707

• Naturally occurring hepatitis B virus (HBV) variants with primary resistance to antiviral therapy and S-mutants with potential primary resistance to adefovir in Argentina.

  Antiviral research 20100701

• Reversible inhibitory effects of saturated and unsaturated alkyl esters on the carboxylesterases activity in rat intestine.

  Lipids 20100701

• Absorption enhancement of adefovir dipivoxil by incorporating MCT and ethyl oleate complex oil phase in emulsion.

  Acta pharmacologica Sinica 20100701

• Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion.

  PLoS pathogens 20100701

• [Resistance mutation patterns of hepatitis B virus in patients with suboptimal response to adefovir dipivoxil therapy after lamivudine resistance].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100701

• [Effect of adefovir and lamivudine combination therapy on lamivudine resistance chronic hepatitis B patients for 48 weeks].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100701

• Emergence of anthrax edema toxin as a master manipulator of macrophage and B cell functions.

  Toxins 20100701

• The Anti-hepatitis B Virus Activity of Boehmeria nivea Extract in HBV-viremia SCID Mice.

  Evidence-based complementary and alternative medicine : eCAM 20100601

• Monitoring of therapy in patients with chronic hepatitis B virus.

  European journal of gastroenterology & hepatology 20100601

• Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro.

  Antiviral research 20100601

• Clinical efficacy of a 24-months course of lamivudine therapy in patients with HBeAg negative chronic hepatitis B: a long-term prospective study.

  Journal of Korean medical science 20100601

• Hepatic Failure Caused by Reactivation of YMDD Mutants Occurring during Preemptive Lamivudine Therapy.

  Gut and liver 20100601

• [Detection of HBV resistant mutations related to lamivudine, adefovir and entecavir by reverse hybridization technique].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100601

• Therapy with nucleos(t)ide analogues: current role in dialysis patients.

  The International journal of artificial organs 20100601

• [Efficacy of the 96-week adefovir dipivoxil therapy in patients with chronic hepatitis B].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20100601

• [Observation on effect of peg interferon lphaa-2a treating lamivudine resistant chronic hepatitis B].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20100601

• Antiviral treatment of chronic hepatitis B virus (HBV) infections.

  Viruses 20100601

• Molecular mechanism of ochratoxin a transport in the kidney.

  Toxins 20100601

• Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation.

  World journal of gastroenterology 20100528

• Avoiding and managing lamivudine resistance in chronic hepatitis B: current approaches and potential strategies including pegylated interferon.

  Liver international : official journal of the International Association for the Study of the Liver 20100501

• Hepatitis B genotypes and response to adefovir treatment in patients with HBV chronic infection.

  The Journal of infection 20100501

• Treatment outcomes of clevudine versus lamivudine at week 48 in naïve patients with HBeAg positive chronic hepatitis B.

  Journal of Korean medical science 20100501

• [Serological and sociodemographic differences in HBV-patients with and without migration background].

  Zeitschrift fur Gastroenterologie 20100501

• Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection.

  Health technology assessment (Winchester, England) 20100501

• [Comparison of the efficacy of 48 week-Entecavir therapy with that of Adefovir therapy for chronic hepatitis B patients].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100501

• On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective.

  Journal of gastroenterology and hepatology 20100501

• Application of hepatitis B virus replication mouse model.

  World journal of gastroenterology 20100428

• [Failure to treat hepatitis B virus infection with adefovir due to early selection of rtA181T mutation].

  Medicina clinica 20100410

• Full-length hepatitis B virus sequences from naïve patients with fluctuation of viral load during ADV monotherapy.

  Virus genes 20100401

• Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion.

  Liver international : official journal of the International Association for the Study of the Liver 20100401

• Computational model of hepatitis B virus DNA polymerase: molecular dynamics and docking to understand resistant mutations.

  Protein science : a publication of the Protein Society 20100401

• Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.

  Journal of hepatology 20100401

• Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance.

  Journal of hepatology 20100401

• Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.

  AIDS patient care and STDs 20100401

• [Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases].

  Mikrobiyoloji bulteni 20100401

• Establishment of a new quantitative detection approach to adefovir-resistant HBV and its clinical application.

  World journal of gastroenterology 20100314

• Combination of Lamivudine and adefovir therapy in HBeAg-positive chronic hepatitis B patients with poor response to adefovir monotherapy.

  Journal of viral hepatitis 20100301

• Lamivudine and adefovir resistance in children and young adults with chronic hepatitis B.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100301

• Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance.

  Journal of viral hepatitis 20100301

• Antiviral activity and safety of LB80380 in hepatitis B e antigen-positive chronic hepatitis B patients with lamivudine-resistant disease.

  Hepatology (Baltimore, Md.) 20100301

• Liver transplantation in bearers of hepatitis B associated or not with delta hepatitis in the age of the new antiviral drugs: is hyperimmune globulin still necessary?

  Transplantation proceedings 20100301

• Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.

  Hepatology international 20100301

• Management of hepatitis B: Pakistan Society for the Study of Liver Diseases (PSSLD) practice guidelines.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20100301

• Management of chronic hepatitis B: experience from China.

  Journal of viral hepatitis 20100301

• rtE218G, a novel hepatitis B virus mutation with resistance to adefovir dipivoxil in patients with chronic hepatitis B.

  Journal of viral hepatitis 20100301

• [Economic evaluation of antiviral treatment for chronic hepatitis B: a systematic review].

  Revista peruana de medicina experimental y salud publica 20100301

• Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus.

  Journal of viral hepatitis 20100201

• Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil.

  Biochemical pharmacology 20100201

• Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants.

  Hepatology research : the official journal of the Japan Society of Hepatology 20100201

• Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy.

  Infection 20100201

• Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T/V polymerase mutations.

  Journal of Korean medical science 20100201

• Clinical management of hepatitis B virus infection correlated with liver transplantation.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20100201

• Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B.

  The Journal of clinical endocrinology and metabolism 20100201

• Highly active antiretroviral therapy improved persistent lamivudine-resistant viremia in acute hepatitis B virus genotype Ae infection with coinfection of human immunodeficiency virus.

  Hepatology research : the official journal of the Japan Society of Hepatology 20100201

• Viral resistance in hepatitis B: prevalence and management.

  Current gastroenterology reports 20100201

• [Short-term efficacy of adefovir dipivoxil as an add-on therapy in the pegylated IFNalpha-2a treatment for HBeAg positive chronic hepatitis B patients].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20100201

• [The effect of antiviral therapy for patients with HBeAg-negative cirrhosis].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20100201

• HIV Genetic Diversity and Drug Resistance.

  Viruses 20100201

• [Protocol for the antiviral therapy of hepatitis B and D].

  Orvosi hetilap 20100103

• A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection.

  Annals of surgical oncology 20100101

• Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B.

  Clinical transplantation 20100101

• Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: a 4-year study.

  Journal of gastroenterology and hepatology 20100101

• In search of a selective therapy of viral infections.

  Antiviral research 20100101

• Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.

  Hepatology (Baltimore, Md.) 20100101

• [Comparison of efficacy between adefovir dipivoxil and entecavir in patients with chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100101

• Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavir.

  PloS one 20100101

• Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006.

  Clinical therapeutics 20100101

• In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.

  PloS one 20100101

• Progressive painless lower limbs weakness in a dialyzed patient: undiagnosed tertiary syphilis: a case report.

  Cases journal 20100101

• Response to adefovir depends on mutation patterns in precore region, basal core promoter and reverse transcriptase, and on-treatment responses in Lamivudine-resistant chronic hepatitis B patients.

  Intervirology 20100101

• Effect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice.

  Journal of translational medicine 20100101

• Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B.

  Antiviral therapy 20100101

• Progress in the use of RNA interference as a therapy for chronic hepatitis B virus infection.

  Genome medicine 20100101

• Forecasting drug utilization and expenditure in a metropolitan health region.

  BMC health services research 20100101

• Kidney function of HIV-infected children in Lagos, Nigeria: using Filler's serum cystatin C-based formula.

  Journal of the International AIDS Society 20100101

• Evaluation of the in vitro anti-HBV activity of clevudine in combination with other nucleoside/nucleotide inhibitors.

  Antiviral therapy 20100101

• Overlap/switch to adefovir monotherapy for lamivudine-resistant patients who responded to combination therapy: a pilot controlled study.

  Internal medicine (Tokyo, Japan) 20100101

• A review of oral antiretroviral therapy for the treatment of chronic hepatitis B.

  The Annals of pharmacotherapy 20100101

• Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.

  BMC gastroenterology 20100101

• Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection.

  Journal of biomedicine & biotechnology 20100101

• Novel mutation in YMDD motif and direct neighbourhood in a child with chronic HBV-infection and clinical lamivudine and adefovir resistance - a scholarly case.

  Virology journal 20100101

• Long term survival and complications after liver transplantation in patients with chronic hepatitis B.

  Annals of transplantation 20100101

• Characterization of immortalized choroid plexus epithelial cell lines for studies of transport processes across the blood-cerebrospinal fluid barrier.

  Cerebrospinal fluid research 20100101

• [The efficacy of adefovir dipivoxil, entecavir and telbivudine for chronic hepatitis B treatment: a systematic review].

  Revista da Sociedade Brasileira de Medicina Tropical 20100101

• Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

  Retrovirology 20100101

• Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review.

  Virology journal 20100101

• Identification of an effective siRNA target site and functional regulatory elements, within the hepatitis B virus posttranscriptional regulatory element.

  Virology journal 20100101

• Development of mathematical models for the analysis of hepatitis delta virus viral dynamics.

  PloS one 20100101

• Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen.

  Clinical epidemiology 20100101

• Recent advances in managing hepatitis B.

  F1000 medicine reports 20100101

• A QSAR study on some series of anti-hepatitis B virus (HBV) agents.

  Bioinformation 20100101

• New approaches to optimize treatment responses in chronic hepatitis B.

  Antiviral therapy 20100101

• Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment.

  PloS one 20100101

• Myotoxicity of telbivudine in pre-existing muscle damage.

  Virology journal 20100101

• Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil.

  Mediators of inflammation 20100101

• Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.

  Antiviral therapy 20100101

• Evolution and suppression of HBV strains with multidrug resistance to lamivudine, adefovir dipivoxil and entecavir in a patient with chronic hepatitis B.

  Antiviral therapy 20100101

• Rituximab administration and reactivation of HBV.

  Hepatitis research and treatment 20100101

• Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck.

  Hepatitis research and treatment 20100101

• Epidemiological and Clinical Features of Hepatitis B Virus Genotypes among Immigrants in Southern Italy.

  Hepatitis research and treatment 20100101

• Can engineered 'designer' T cells outsmart chronic hepatitis B?

  Hepatitis research and treatment 20100101

• Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients.

  Mediterranean journal of hematology and infectious diseases 20100101

• Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India.

  Indian journal of sexually transmitted diseases and AIDS 20100101

• An update on the use of Atripla in the treatment of HIV in the United States.

  HIV/AIDS (Auckland, N.Z.) 20100101

• Molecular diagnosis of entecavir resistance.

  Hepatitis monthly 20100101

• Entecavir therapy in Turkish adult patients with chronic hepatitis B: one-year results from Izmir province, Turkey.

  Hepatitis monthly 20100101

• Evaluation of the effects of oral N-acetylcysteine and a placebo in paraclinical and oxidative stress parameters of patients with chronic hepatitis B.

  Hepatitis monthly 20100101

• Multidrug-resistant hepatitis B virus strain in a chronic Turkish patient.

  Hepatitis monthly 20100101

• The effectiveness of nucleoside analogues in chronic hepatitis B patients unresponsive to interferon therapy: our clinical trials for one year.

  Hepatitis monthly 20100101

• Prevalence and clinical significance of hepatitis B Basal core promoter and precore gene mutations in southern Iranian patients.

  Hepatitis monthly 20100101

• High hepatitis B virus load in a patient with severe polyarthritis nodosa.

  Hepatitis monthly 20100101

• Design, synthesis and evaluation of novel oxazaphosphorine prodrugs of 9-(2-phosphonomethoxyethyl)adenine (PMEA, adefovir) as potent HBV inhibitors.

  Bioorganic & medicinal chemistry letters 20091215

• Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles.

  Journal of viral hepatitis 20091201

• Liver transplantation for acute-on-chronic liver failure.

  Hepatology international 20091201

• Favorable outcome of de novo hepatitis B infection after liver transplantation with lamivudine and adefovir therapy.

  Transplant infectious disease : an official journal of the Transplantation Society 20091201

• Current status of liver diseases in Korea: hepatitis B.

  The Korean journal of hepatology 20091201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20091201

• [Chronic hepatitis B therapy].

  Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20091201

• [Management of side effects during antiviral therapy].

  Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20091201

• [Efficacy and durability of generic adefovir dipivoxil in patients with HBeAg positive chronic hepatitis].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20091201

• HBV and HCV therapy.

  Viruses 20091201

• Tenofovir disoproxil fumarate: in chronic hepatitis B.

  Drugs 20091112

• Monotherapy versus combination therapy for the treatment of chronic hepatitis B.

  Expert opinion on investigational drugs 20091101

• Decrease in viral load at weeks 12 and 24 in patients with chronic hepatitis B treated with lamivudine or adefovir predicts virological response at week 48.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20091101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20091101

• Combination treatment in HBeAg-negative chronic hepatitis B.

  World journal of hepatology 20091031

• Current trends in chronic hepatitis B management: results of a questionnaire.

  European journal of gastroenterology & hepatology 20091001

• Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B.

  Journal of hepatology 20091001

• Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome.

  Journal of hepatology 20091001

• Current management of hepatitis B virus infection before and after liver transplantation.

  Liver international : official journal of the International Association for the Study of the Liver 20091001

• Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.

  Hepatology (Baltimore, Md.) 20091001

• Detection of the rtA181V/T and rtN236T mutations associated with resistance to adefovir dipivoxil using a ligase detection reaction assay.

  Clinica chimica acta; international journal of clinical chemistry 20091001

• Tenofovir for the treatment of hepatitis B virus.

  Pharmacotherapy 20091001

• Telbivudine for the treatment of chronic hepatitis B infection.

  Health technology assessment (Winchester, England) 20091001

• Entecavir for the treatment of chronic hepatitis B infection.

  Health technology assessment (Winchester, England) 20091001

• [The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20091001

• [Dissection of mechanism for the adefovir dipivoxil resistance in chronic hepatitis B patients].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20091001

• Lenalidomide-induced acute liver failure.

  Blood transfusion = Trasfusione del sangue 20091001

• [Analysis and recombinant construction of HBV the reverse transcriptase gene with drug-resistant mutations from 40 patients with chronic hepatitis B].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20091001

• Hepatitis B virus infected health care workers in The Netherlands, 2000-2008.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090901

• Pharmacokinetics of tacrolimus co-administered with adefovir dipivoxil to liver transplant recipients.

  Liver international : official journal of the International Association for the Study of the Liver 20090901

• Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil.

  Hepatology (Baltimore, Md.) 20090901

• Dynamic changes of HBV quasispecies and deletion patterns in a chronic hepatitis B patient.

  Journal of medical virology 20090901

• Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand.

  Hepatology international 20090901

• Clinical outcome of lamivudine-resistant chronic hepatitis B patients with compensated cirrhosis under adefovir salvage treatment. Importance of HCC surveillance.

  European journal of internal medicine 20090901

• [Non-standard discontinuation of adefovir dipivoxil causing acute exacerbation of hepatitis].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20090901

• [Prevention and management of hepatitis B virus reinfection after liver transplantation].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20090815

• Stop codon read-through of a methylmalonic aciduria mutation.

  Molecular genetics and metabolism 20090801

• Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients.

  Journal of gastroenterology and hepatology 20090801

• Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus.

  Medical microbiology and immunology 20090801

• [Factors associated with response to lamivudine: retrospective study of 233 patients with chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20090801

• [The analyse of effectiveness in HBeAg-positive chronic viral hepatitis B treated by adefovir dipivoxil combined with bicyclol].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20090801

• Early development of clevudine resistance during clevudine therapy in a patient with chronic hepatitis B who received prior lamivudine therapy.

  Liver international : official journal of the International Association for the Study of the Liver 20090701

• Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivo.

  Antimicrobial agents and chemotherapy 20090701

• Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation.

  Health technology assessment (Winchester, England) 20090701

• [A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20090701

• Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues.

  Current opinion in organ transplantation 20090601

• Synthesis and antiviral activity evaluation of acyclic 2'-azanucleosides bearing a phosphonomethoxy function in the side chain.

  Bioorganic & medicinal chemistry 20090601

• Salvage therapy with tenofovir followed by adefovir maintenance in a cirrhotic patient with a lamivudine resistant HBV flare.

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20090601

• Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity.

  Prescrire international 20090601

• [The antiviral treatment impacts on clinical outcomes of renal transplantation recipients with hepatitis B virus infection].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20090601

• Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation.

  World journal of gastroenterology 20090528

• Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients.

  The Journal of infectious diseases 20090501

• Mutations associated with the therapeutic efficacy of adefovir dipivoxil added to lamivudine in patients resistant to lamivudine with type B chronic hepatitis.

  Journal of medical virology 20090501

• Spondyloarthropathy and chronic B hepatitis. Effect of anti-TNF therapy.

  Joint, bone, spine : revue du rhumatisme 20090501

• Update on viral hepatitis: 2008.

  Current opinion in gastroenterology 20090501

• Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.

  Seminars in liver disease 20090501

• Antiviral resistance and hepatitis B therapy.

  Hepatology (Baltimore, Md.) 20090501

• Benefits and risks of combination therapy for hepatitis B.

  Hepatology (Baltimore, Md.) 20090501

• Side effects of long-term oral antiviral therapy for hepatitis B.

  Hepatology (Baltimore, Md.) 20090501

• Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.

  Antiviral research 20090501

• [Antiviral efficacy of lamivudine/adefovir combination therapy in chronic hepatitis b patients with resistance to lamivudine and adefovir consecutively].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20090501

• [Treatment of hepatitis B virus resistant to lamivudine and adefovir].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20090501

• The option of liver transplantation for hepatitis B: where are we?

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090501

• Liver transplantation for hepatitis B virus. Pre-emptive and peri-operative prophylaxis.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090501

• [Mutation patterns in the RT region of hepatitis B virus P gene in patients treated with nucleoside/nucleotide analogs].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20090501

• [The clinical study of adding on adefovir dipivoxil to treat for lamivudine resistant patients with chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20090501

• Clevudine for hepatitis B.

  Drugs of today (Barcelona, Spain : 1998) 20090501

• [Telbivudine in the management of HIV/HBV coinfection. Treating hepatitis B without HIV trouble].

  MMW Fortschritte der Medizin 20090430

• Dimethylamino acid esters as biodegradable and reversible transdermal permeation enhancers: effects of linking chain length, chirality and polyfluorination.

  Pharmaceutical research 20090401

• Gene induction for the treatment of methylmalonic aciduria.

  The journal of gene medicine 20090401

• A short course of add-on adefovir dipivoxil treatment in lamivudine-resistant chronic hepatitis B patients.

  Journal of viral hepatitis 20090401

• Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy.

  Journal of hepatology 20090401

• Partial virological response to nucleos(t)ide analogues in naïve patients with chronic hepatitis B: From guidelines to field practice.

  Journal of hepatology 20090401

• Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.

  Liver international : official journal of the International Association for the Study of the Liver 20090401

• Decision analysis model for hepatitis B prophylaxis one year after liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20090401

• Treatment of chronic hepatitis B: focus on telbivudine.

  Expert review of anti-infective therapy 20090401

• Chronic hepatitis B: who to treat and which choice of treatment?

  Expert review of anti-infective therapy 20090401

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090401

• Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure.

  Liver international : official journal of the International Association for the Study of the Liver 20090301

• Assessment of selective real-time PCR for quantitation of lamivudine and adefovir hepatitis B virus-resistant strains and comparison with direct sequencing and line probe assays.

  Journal of virological methods 20090301

• Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir.

  Journal of medical virology 20090301

• Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.

  Journal of medical virology 20090301

• Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus.

  Journal of viral hepatitis 20090301

• Diagnosis and treatment of chronic hepatitis B: 2009 update.

  Minerva gastroenterologica e dietologica 20090301

• Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides.

  Journal of viral hepatitis 20090301

• [A study on the treatment of chronic hepatitis B with YMDD mutation].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20090301

• [Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea].

  The Korean journal of hepatology 20090301

• [Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, lamivudine-resistant chronic hepatitis B patients].

  The Korean journal of hepatology 20090301

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090301

• Hepatitis B in HIV patients: what is the current treatment and what are the challenges?

  Journal of HIV therapy 20090301

• Adefovir dipivoxil-induced acute tubular necrosis and Fanconi syndrome in a renal transplant patient.

  AIDS (London, England) 20090220

• Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients.

  World journal of gastroenterology 20090214

• Telbivudine, a nucleoside analog inhibitor of HBV polymerase, has a different in vitro cross-resistance profile than the nucleotide analog inhibitors adefovir and tenofovir.

  Antiviral research 20090201

• Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: a seven-year follow-up study.

  Journal of medical virology 20090201

• Role of combination therapy in chronic hepatitis B.

  Current gastroenterology reports 20090201

• On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeks.

  Journal of viral hepatitis 20090201

• [Prevention and therapy of reactivation of hepatitis B in immunosuppressed patients].

  Deutsche medizinische Wochenschrift (1946) 20090201

• Antiviral therapy for hepatitis B virus associated hepatic failure.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20090201

• Hepatitis B therapy in children.

  Expert review of gastroenterology & hepatology 20090201

• Rapid and specific liquid chromatographic tandem mass spectrometric determination of tenofovir in human plasma and its fragmentation study.

  Journal of chromatographic science 20090201

• [Atazanavir-induced nephrolithiasis].

  Enfermedades infecciosas y microbiologia clinica 20090201

• [Analysis of the correlation between the pre-S1 antigen, pre-S2 antigen and DNA of hepatitis B virus in the serum of chronic hepatitis B patients undergoing nucleoside analogue therapy.].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20090201

• Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside/nucleotide analogues.

  Clinical therapeutics 20090201

• Activation of protein kinase Czeta increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated transport.

  The Journal of biological chemistry 20090130

• Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.

  Annals of internal medicine 20090120

• Hepatitis B and liver transplantation: 2008 update.

  Reviews in medical virology 20090101

• Serum HBsAg changes in HBeAg positive chronic hepatitis B patients with continuous viral load reductions during treatment with adefovir or peg-interferon-alpha-2a.

  Antiviral research 20090101

• In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.

  Gastroenterology 20090101

• Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.

  Journal of hepatology 20090101

• Natural products as promising drug candidates for the treatment of hepatitis B and C.

  Acta pharmacologica Sinica 20090101

• Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.

  Hepatology (Baltimore, Md.) 20090101

• Complex dynamics of hepatitis B virus resistance to adefovir.

  Hepatology (Baltimore, Md.) 20090101

• Effective treatment of respiratory alphaherpesvirus infection using RNA interference.

  PloS one 20090101

• Bicyclol: a novel drug for treating chronic viral hepatitis B and C.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20090101

• Dual hepatitis virus infections in liver transplant: case report and a review of the literature.

  Clinical transplantation 20090101

• Emergence of adefovir-resistant mutants after reversion to YMDD wild-type in lamivudine-resistant patients receiving adefovir monotherapy.

  Journal of gastroenterology and hepatology 20090101

• Renal side effects of adefovir in hepatitis B virus-(HBV) positive kidney allograft recipients.

  Clinical nephrology 20090101

• Treatment of HBeAg-positive patients with nucleos/tide analogues.

  Liver international : official journal of the International Association for the Study of the Liver 20090101

• HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues.

  Liver international : official journal of the International Association for the Study of the Liver 20090101

• How to compare antivirals in the treatment of chronic hepatitis B?

  Annals of clinical microbiology and antimicrobials 20090101

• On-treatment outcome prediction and adjustment during chronic hepatitis B therapy: now and future.

  Antiviral therapy 20090101

• Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues.

  Antiviral chemistry & chemotherapy 20090101

• Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B.

  Journal of gastroenterology 20090101

• Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?

  Antiviral therapy 20090101

• Clinical usefulness of sequential hepatitis B virus DNA measurement (the roadmap concept) during adefovir treatment in lamivudine-resistant patients.

  Antiviral therapy 20090101

• Tenofovir and its potential in the treatment of hepatitis B virus.

  Therapeutics and clinical risk management 20090101

• The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study.

  Retrovirology 20090101

• Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B.

  Journal of gastroenterology 20090101

• Fatal lactic acidosis associated with the use of combination oral medications to treat reactivation of hepatitis B.

  Journal of clinical gastroenterology 20090101

• The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era.

  Antiviral therapy 20090101

• Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B.

  Antiviral therapy 20090101

• HBV DNA level as an important determinant of E antigen seroconversion of chronic hepatitis B during adefovir dipivoxil therapy.

  Hepato-gastroenterology 20090101

• Analogs and fibrosis regression in hepatitis B.

  Gastroenterologie clinique et biologique 20090101

• Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.

  Antiviral therapy 20090101

• The significance of enzyme immunoassay for the assessment of hepatitis B virus core-related antigen following liver transplantation.

  Internal medicine (Tokyo, Japan) 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090101

• Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA.

  BMC gastroenterology 20090101

• Two types of drug-resistant hepatitis B viral strains emerging alternately and their susceptibility to combination therapy with entecavir and adefovir.

  Antiviral therapy 20090101

• Meta-analysis: adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus.

  Virology journal 20090101

• B7-DC-silenced dendritic cells induce stronger anti-HBV immunity in transgenic mice.

  Archives of virology 20090101

• Safety and efficacy of telbivudine for the treatment of chronic hepatitis B.

  Therapeutics and clinical risk management 20090101

• Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir.

  Antiviral therapy 20090101

• Determination of adefovir by LC-ESI-MS-MS and its application to a pharmacokinetic study in healthy Chinese volunteers.

  Journal of chromatographic science 20090101

• No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products--a pilot study.

  Orphanet journal of rare diseases 20090101

• Lenalidomide, melphalan, and prednisone association is an effective salvage therapy in relapsed plasma cell leukaemia.

  Journal of oncology 20090101

• Serum levels of surface large envelope proteins: prognostic markers for hepatitis B e antigen-negative patients with adefovir dipivoxil treatment.

  Antiviral therapy 20090101

• A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B.

  Antiviral therapy 20090101

• Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007-2008.

  PloS one 20090101

• Hepatitis B and C in hematopoietic stem cell transplant.

  Mediterranean journal of hematology and infectious diseases 20090101

• Prevention and treatment of hepatitis virus infections in hematopoietic stem cell transplant recipients.

  Mediterranean journal of hematology and infectious diseases 20090101

• Management of HBV infection during immunosuppressive treatment.

  Mediterranean journal of hematology and infectious diseases 20090101

• Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.

  Mediterranean journal of hematology and infectious diseases 20090101

• Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report.

  BMJ case reports 20090101

• New approaches in the management of chronic hepatitis B: role of tenofovir.

  Infection and drug resistance 20090101

• Pregnancy and sexually transmitted viral infections.

  Indian journal of sexually transmitted diseases and AIDS 20090101

• Structural insights into the catalytic mechanism of the bacterial class B phosphatase AphA belonging to the DDDD superfamily of phosphohydrolases.

  Journal of molecular biology 20081212

• [Protocol for the antiviral therapy of chronic hepatitis B].

  Orvosi hetilap 20081207

• Current treatment indications and strategies in chronic hepatitis B virus infection.

  World journal of gastroenterology 20081207

• Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

  The New England journal of medicine 20081204

• Chronic hepatitis B--new goals, new treatment.

  The New England journal of medicine 20081204

• Understanding the molecular basis of HBV drug resistance by molecular modeling.

  Antiviral research 20081201

• A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20081201

• How effective is adefovir dipivoxil plus lamivudine for the treatment of lamivudine-resistant chronic hepatitis B?

  Nature clinical practice. Gastroenterology & hepatology 20081201

• Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers.

  European journal of gastroenterology & hepatology 20081201

• Clevudine: a promising therapy for the treatment of chronic hepatitis B.

  Expert opinion on investigational drugs 20081201

• Failure of adefovir 20 mg to improve suboptimal response in lamivudine-resistant hepatitis B patients treated with adefovir 10 mg and lamivudine.

  Journal of viral hepatitis 20081201

• [The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection].

  The Korean journal of hepatology 20081201

• [Therapy of chronic hepatitis B].

  Acta gastroenterologica Latinoamericana 20081201

• Therapeutic strategies for chronic hepatitis B virus infection in 2008.

  The American journal of medicine 20081201

• Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study.

  Hepatology international 20081201

• Are hepatitis B e antigen (HBeAg)-positive chronic hepatitis B and HBeAg-negative chronic hepatitis B distinct diseases?

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20081115

• Sustained hepatitis B e antigen seroconversion in patients with chronic hepatitis B after adefovir dipivoxil treatment: analysis of precore and basal core promoter mutants.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20081115

• The discovery of antiviral agents: ten different compounds, ten different stories.

  Medicinal research reviews 20081101

• Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy.

  Journal of hepatology 20081101

• Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV.

  Digestive diseases and sciences 20081101

• Permeation enhancer dodecyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: influence of pH, ion-pairing and skin species.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20081101

• Does the presence of adefovir-resistant variants lead to failure of tenofovir monotherapy?

  Journal of hepatology 20081101

• A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis.

  Hepatology (Baltimore, Md.) 20081101

• Hepatitis B virus genotype-associated variability in antiviral response to adefovir dipivoxil therapy in Chinese Han population.

  The Tohoku journal of experimental medicine 20081101

• [Development of clevudine resistance after switching from lamivudine in a patient with chronic hepatitis B].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20081101

• [Chronic hepatitis B: current therapy].

  Bulletin de l'Academie nationale de medecine 20081101

• Core promoter mutant HBV non-responding to adefovir after viral breakthrough on lamivudine: rapid virologic response to tenofovir plus lamivudine in a cirrhotic patient.

  European journal of medical research 20081027

• [New data and recommendations of antiviral therapy of chronic hepatitis B and C].

  Der Internist 20081001

• A review of telbivudine for the management of chronic hepatitis B virus infection.

  Expert opinion on drug metabolism & toxicology 20081001

• Pharmacoeconomics of entecavir treatment for chronic hepatitis B.

  Expert opinion on pharmacotherapy 20081001

• LB80380: a promising new drug for the treatment of chronic hepatitis B.

  Expert opinion on investigational drugs 20081001

• Resistance issues in treating chronic hepatitis B.

  Future microbiology 20081001

• Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosis.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20081001

• Liver transplantation for hepatitis B: what is the best hepatitis B immune globulin/antiviral regimen?

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20081001

• Therapy of chronic hepatitis B: trends and developments.

  Current opinion in pharmacology 20081001

• [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20081001

• [Multiple-site analysis of HBV drug-resistant mutations in 340 patients with chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20081001

• Lopinavir/ritonavir in the treatment of HIV-1 infection: a review.

  Therapeutics and clinical risk management 20081001

• Management of chronic hepatitis B.

  Evidence report/technology assessment 20081001

• [Prophylaxsis against recurrance of hepatitis B virus after liver transplantation].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20081001

• Assessment of liver fibrosis: noninvasive means.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20081001

• Clinical pharmacology.

  Indian journal of pharmacology 20081001

• Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir.

  The Journal of antimicrobial chemotherapy 20080901

• Continuous single motor unit electromyographic activity in adefovir associated myopathy.

  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20080901

• What is the optimum dose of adefovir in the treatment of chronic hepatitis B infection?

  Journal of hepatology 20080901

• Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

  Hepatology (Baltimore, Md.) 20080901

• [A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus].

  The Korean journal of hepatology 20080901

• [Construction of full-length genome HBV plasmid with adefovir dipivoxil drug-resistance gene in RT domain of polymerase].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20080901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20080901

• Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update.

  Hepatology international 20080901

• Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B.

  Hepatology international 20080901

• The Roadmap concept: using early on-treatment virologic responses to optimize long-term outcomes for patients with chronic hepatitis B.

  Hepatology international 20080901

• Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B.

  Hepatology international 20080901

• Errata.

  Hepatology international 20080901

• Entecavir therapy for adefovir-resistant hepatitis B virus infection in kidney and liver allograft recipients.

  Transplantation 20080827

• Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.

  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20080801

• Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector.

  The Journal of general virology 20080801

• New paradigms for the treatment of chronic hepatitis B.

  Journal of gastroenterology and hepatology 20080801

• The treatment of chronic hepatitis B: Focus on adefovir-like antivirals.

  Therapeutics and clinical risk management 20080801

• Rapid re-emergence of YMDD mutation of hepatitis B virus with hepatic decompensation after lamivudine retreatment.

  World journal of gastroenterology 20080721

• Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis.

  Liver international : official journal of the International Association for the Study of the Liver 20080701

• Efficacy of cationic lipid-DNA complexes (CLDC) on hepatitis B virus in transgenic mice.

  Antiviral research 20080701

• Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy.

  Journal of medical virology 20080701

• Review article: current antiviral therapy of chronic hepatitis B.

  Alimentary pharmacology & therapeutics 20080701

• The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound.

  Hepatology (Baltimore, Md.) 20080701

• [YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy].

  Mikrobiyoloji bulteni 20080701

• Down-regulation of Na+/H+ exchanger regulatory factor 1 increases expression and function of multidrug resistance protein 4.

  Cancer research 20080615

• Replication of clinical hepatitis B virus isolate and its application for selecting antiviral agents for chronic hepatitis B patients.

  World journal of gastroenterology 20080614

• Transdermal and dermal delivery of adefovir: effects of pH and permeation enhancers.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080601

• The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene.

  The Journal of pharmacology and experimental therapeutics 20080601

• Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis.

  Alimentary pharmacology & therapeutics 20080601

• Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.

  Gastroenterology 20080601

• Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B.

  Hepatology (Baltimore, Md.) 20080601

• Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up.

  Journal of hepatology 20080601

• Current antiviral therapies for chronic hepatitis B.

  Hepatology research : the official journal of the Japan Society of Hepatology 20080601

• Prevention of hepatitis B recurrence after living donor liver transplantation: primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20080601

• Solid lipid nanoparticles loading adefovir dipivoxil for antiviral therapy.

  Journal of Zhejiang University. Science. B 20080601

• [Comparison of antiviral responses to adefovir dipivoxil therapy of genotype B and genotype C HBV infected patients].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20080601

• [Lamivudine and adefovir dipivoxil combination treatment for liver cirrhosis patients with CHB].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20080601

• [Management of chronic hepatitis B in treatment-naive patients].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080601

• [Management of antiviral-resistant chronic hepatitis B virus infection].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080601

• Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B.

  Hepatology international 20080601

• Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure.

  Hepatology international 20080601

• Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues.

  Hepatology international 20080601

• Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV).

  Hepatology international 20080601

• [Drug approval studies of Viread. As effective in HBeAg positive as also in HBeAg negative patients].

  MMW Fortschritte der Medizin 20080522

• 96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B.

  Journal of hepatology 20080501

• Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B.

  Journal of viral hepatitis 20080501

• 6-mercaptopurine and 9-(2-phosphonyl-methoxyethyl) adenine (PMEA) transport altered by two missense mutations in the drug transporter gene ABCC4.

  Human mutation 20080501

• Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B.

  Journal of hepatology 20080501

• Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure.

  Journal of hepatology 20080501

• Update on viral hepatitis: 2007.

  Current opinion in gastroenterology 20080501

• Current treatment of HIV/hepatitis B virus coinfection.

  Journal of gastroenterology and hepatology 20080501

• [Acute hepatitis B: is antiviral therapy indicated? Two case reports].

  Deutsche medizinische Wochenschrift (1946) 20080501

• [The predictive value of ALT, HBeAg and HBV DNA levels at baseline and the degree of HBV suppression at week 12 adefovir dipivoxil treatment to the efficacy of it at week 52 in patients with HBeAg-positive chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20080501

• [Adefovir dipivoxil treatment of hepatic cirrhosis complicated with hepatitis B virus associated glomerulonephritis].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20080501

• [Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates].

  Yao xue xue bao = Acta pharmaceutica Sinica 20080501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20080501

• [Interferon in hepatitis B].

  Enfermedades infecciosas y microbiologia clinica 20080501

• [Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B].

  Enfermedades infecciosas y microbiologia clinica 20080501

• [Entecavir].

  Enfermedades infecciosas y microbiologia clinica 20080501

• [Resistance in hepatitis B virus].

  Enfermedades infecciosas y microbiologia clinica 20080501

• [Clinical management of patients with chronic hepatitis B virus infection].

  Enfermedades infecciosas y microbiologia clinica 20080501

• [Hepatitis B in patients with HIV infection].

  Enfermedades infecciosas y microbiologia clinica 20080501

• Current approaches for treating chronic hepatitis B: when to start, what to start with, and when to stop.

  Hepatology international 20080501

• Viral persistence after liver transplantation for hepatitis B virus: a cross-sectional study.

  Transplantation 20080427

• Clinical and therapeutical importance of HBV genotyping in Romania.

  Journal of medicine and life 20080415

• Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis.

  British journal of cancer 20080408

• The pharmacokinetics and safety of adefovir dipivoxil in children and adolescents with chronic hepatitis B virus infection.

  Journal of clinical pharmacology 20080401

• Lamivudine-resistant chronic hepatitis B: an observational study on adefovir in monotherapy or in combination with lamivudine.

  Journal of hepatology 20080401

• Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20080401

• Economic evaluation of chronic hepatitis B treatments in Taiwan.

  Journal of gastroenterology and hepatology 20080401

• Acyclic phosphonate nucleotides and human adenylate kinases: impact of a borano group on alpha-P position.

  Nucleosides, nucleotides & nucleic acids 20080401

• Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination.

  The Journal of biological chemistry 20080328

• Short-term overlap lamivudine treatment with adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B.

  World journal of gastroenterology 20080321

• [Prevention and treatment of hepatitis B recurrence after liver transplantation].

  Zhonghua yi xue za zhi 20080304

• Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.

  The Lancet. Infectious diseases 20080301

• Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations.

  Journal of hepatology 20080301

• Chronic hepatitis B: preventing, detecting, and managing viral resistance.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20080301

• [Pharmacological agents for the treatment of chronic hepatitis B].

  Gastroenterologia y hepatologia 20080301

• [Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients].

  The Korean journal of hepatology 20080301

• [New treatment options in chronic hepatitis B].

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20080301

• Severe acute pancreatitis related to the use of adefovir in a liver transplant recipient.

  Gastroenterologie clinique et biologique 20080301

• [The ABC of viral hepatitis].

  Journal de pharmacie de Belgique 20080301

• Pradefovir: a prodrug that targets adefovir to the liver for the treatment of hepatitis B.

  Journal of medicinal chemistry 20080214

• Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.

  Alimentary pharmacology & therapeutics 20080201

• [Current data on the treatment of chronic hepatitis B].

  Presse medicale (Paris, France : 1983) 20080201

• Development of a real-time quantitative reverse transcriptase PCR assay for detection of the Friend leukemia virus load in murine plasma.

  Journal of virological methods 20080201

• Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression.

  Journal of viral hepatitis 20080201

• Entecavir for chronic hepatitis B: a review.

  Therapeutic drug monitoring 20080201

• Targeting human DNA polymerase alpha for the inhibition of keratinocyte proliferation. Part 1. Homology model, active site architecture and ligand binding.

  Journal of enzyme inhibition and medicinal chemistry 20080201

• Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.

  Clinical therapeutics 20080201

• [Protocol for the treatment of chronic viral hepatitis].

  Orvosi hetilap 20080120

• Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future.

  Reviews in medical virology 20080101

• Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years.

  Liver international : official journal of the International Association for the Study of the Liver 20080101

• RNAi for treating hepatitis B viral infection.

  Pharmaceutical research 20080101

• Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil.

  BMC microbiology 20080101

• [Kinetics of HBV mutants conferring adefovir resistance (rtn236t) and a method to detect them rapidly].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20080101

• Quantification of lamivudine-resistant hepatitis B virus mutants by type-specific TaqMan minor groove binder probe assay in patients with chronic hepatitis B.

  Annals of clinical biochemistry 20080101

• Sustained virological and biochemical responses to lamivudine and adefovir dipivoxil combination in a chronic hepatitis B infection despite mutations conferring resistance to both drugs.

  Comparative hepatology 20080101

• New drugs for chronic hepatitis B: a review.

  American journal of therapeutics 20080101

• Acute renal failure in an AIDS patient on tenofovir: a case report.

  Journal of medical case reports 20080101

• Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.

  Antiviral therapy 20080101

• Gln151 of HIV-1 reverse transcriptase acts as a steric gate towards clinically relevant acyclic phosphonate nucleotide analogues.

  Antiviral therapy 20080101

• Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases.

  Reumatismo 20080101

• Comparison of the Cobas Ampliprep/Cobas TaqMan HBV Test versus the Cobas Amplicor HBV monitor for HBV-DNA detection and quantification during antiviral therapy.

  The new microbiologica 20080101

• [Treatment recommendations of chronic hepatitis B. Did the world escape us?].

  Przeglad epidemiologiczny 20080101

• Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants.

  Antiviral therapy 20080101

• Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.

  Antiviral therapy 20080101

• Treatment of chronic hepatitis B infection: an update of Swedish recommendations.

  Scandinavian journal of infectious diseases 20080101

• An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load.

  PloS one 20080101

• A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients.

  PloS one 20080101

• [Treatment of chronic hepatitis B in HIV co-infected patients].

  Gastroenterologie clinique et biologique 20080101

• [Liver transplantation for chronic hepatitis B].

  Gastroenterologie clinique et biologique 20080101

• [Combination therapy in chronic hepatitis B].

  Gastroenterologie clinique et biologique 20080101

• [Is it possible to stop nucleos(t)ide analogue based therapy in chronic hepatitis B?].

  Gastroenterologie clinique et biologique 20080101

• [The patient with uncontrolled chronic hepatitis B].

  Gastroenterologie clinique et biologique 20080101

• Treatment of chronic hepatitis B virus infection - Dutch national guidelines.

  The Netherlands journal of medicine 20080101

• A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.

  Antiviral therapy 20080101

• Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients.

  Antiviral therapy 20080101

• [Treatment of chronic hepatitis B].

  Gastroenterologie clinique et biologique 20080101

• Living donor liver transplantation for hepatitis B associated liver diseases: a 10-year experience in a single center.

  Hepato-gastroenterology 20080101

• Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients.

  BMC infectious diseases 20080101

• Viral hepatitis in elderly haemodialysis patients: current prevention and management strategies.

  Drugs & aging 20080101

• Gateways to clinical trials. July-August 2008.

  Methods and findings in experimental and clinical pharmacology 20080101

• A cost-effectiveness analysis of currently approved treatments for HBeAg-positive chronic hepatitis B.

  PharmacoEconomics 20080101

• Pharmacotherapy of hepatitis B infection: a brief review.

  Nephrology nursing journal : journal of the American Nephrology Nurses' Association 20080101

• Anthrax edema toxin modulates PKA- and CREB-dependent signaling in two phases.

  PloS one 20080101

• Treatment of chronic hepatitis B: will entecavir and telbivudine do the trick?

  Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20080101

• An earthworm protease cleaving serum fibronectin and decreasing HBeAg in HepG2.2.15 cells.

  BMC biochemistry 20080101

• The oncogenic potential of hepatitis B virus rtA181T/ surface truncation mutant.

  Antiviral therapy 20080101

• Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.

  Antiviral therapy 20080101

• [Drugs treatment of hepatitis B].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20080101

• Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success.

  Best practice & research. Clinical gastroenterology 20080101

• Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.

  Best practice & research. Clinical gastroenterology 20080101

• Adefovir for chronic hepatitis B treatment: identification of virological markers linked to therapy response.

  Antiviral therapy 20080101

• Virological response and hepatocarcinogenesis in lamivudine-resistant hepatitis B virus genotype C patients treated with lamivudine plus adefovir dipivoxil.

  Intervirology 20080101

• Lamivudine therapy for korean children with chronic hepatitis B.

  Yonsei medical journal 20071231

• Telbivudine: a new treatment for chronic hepatitis B.

  World journal of gastroenterology 20071214

• Summaries for patients. Antiviral therapy for chronic hepatitis B.

  Annals of internal medicine 20071204

• Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial.

  Annals of internal medicine 20071204

• Adefovir dipivoxil alone or in combination with lamivudine for three months in patients with lamivudine resistant compensated chronic hepatitis B.

  Digestive diseases and sciences 20071201

• Transport of a fluorescent cAMP analog in teleost proximal tubules.

  American journal of physiology. Regulatory, integrative and comparative physiology 20071201

• Hepatitis B virus genotype E detected in Brazil in an African patient who is a frequent traveler.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20071201

• Successful treatment of an entecavir-resistant hepatitis B virus variant.

  Journal of medical virology 20071201

• Living donor liver transplantation for hepatitis B cirrhosis.

  Journal of gastroenterology and hepatology 20071201

• Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.

  Journal of gastroenterology and hepatology 20071201

• Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages.

  PLoS pathogens 20071201

• Review article: Success and failure of nucleoside and nucleotide analogues in chronic hepatitis B.

  Alimentary pharmacology & therapeutics 20071201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20071201

• Treatment of Hepatitis B e Antigen-negative Patients.

  Current treatment options in gastroenterology 20071201

• Clinical implications of resistance patterns against HBV-polymerase inhibitors for the treatment of chronic hepatitis B.

  Journal of HIV therapy 20071201

• The role of entecavir in the treatment of chronic hepatitis B.

  Therapeutics and clinical risk management 20071201

• Review of tenofovir-emtricitabine.

  Therapeutics and clinical risk management 20071201

• Secretion of antiretroviral chemokines by human cells cultured with acyclic nucleoside phosphonates.

  European journal of pharmacology 20071121

• Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B.

  Alimentary pharmacology & therapeutics 20071115

• Hepatitis B virus containing the I233V mutation in the polymerase reverse-transcriptase domain remains sensitive to inhibition by adefovir.

  The Journal of infectious diseases 20071115

• [Attention-getting sexually transmitted diseases: Hepatitis B].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20071110

• Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(t)ide analogues.

  Journal of medical virology 20071101

• Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.

  Journal of medical virology 20071101

• Successful living donor liver transplantation using a graft from a hepatitis B surface antigen-positive donor.

  Liver international : official journal of the International Association for the Study of the Liver 20071101

• The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore.

  Journal of viral hepatitis 20071101

• Management of hepatitis B in liver transplant recipients.

  Journal of viral hepatitis 20071101

• [Adefovir in reactivation of chemotherapy-induced hepatitis B in an anti-Hbc-positive patient].

  Gastroenterologia y hepatologia 20071101

• Oral antivirals for chronic hepatitis B.

  Clinics in liver disease 20071101

• Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.

  Clinics in liver disease 20071101

• Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients.

  Gastroenterology 20071101

• [A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20071101

• [Fatal liver failure after hepatitis B reactivation following chemotherapy for lymphoma in a patient with only anti-HBc antibody and review of the literature].

  Gastroenterologie clinique et biologique 20071101

• Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity.

  Journal of acquired immune deficiency syndromes (1999) 20071101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20071101

• [Diagnosis and treatment of chronic hepatitis B. Recommendations of the Czech Hepatology Society of the J. E. Purkinje Medical Society and the Society of Infectious Medicine of the J.E. Purkinje Medical Society].

  Vnitrni lekarstvi 20071101

• [Adefovir dipivoxil compassionate use program in Spain: efficacy and resistance analysis].

  Medicina clinica 20071027

• Room temperature ionic liquid as matrix medium for the determination of residual solvents in pharmaceuticals by static headspace gas chromatography.

  Journal of chromatography. A 20071005

• Combination therapy in liver transplant recipients with hepatitis B virus without hepatitis B immune globulin.

  Digestive diseases and sciences 20071001

• Absence of a pharmacokinetic interaction between entecavir and adefovir.

  Journal of clinical pharmacology 20071001

• Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials.

  Journal of hepatology 20071001

• Adefovir for lamivudine resistant HBV: more than meets the eye.

  Journal of hepatology 20071001

• [Indications for antiviral therapy for chronic hepatitis B].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20071001

• [Therapy for chronic hepatitis B: relationship between HBV genotype and efficacy or resistance of anti-viral therapy].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20071001

• [Recent therapies for hepatitis B (discussion)].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20071001

• The high incidence of the emergence of entecavir-resistant mutants among patients infected with lamivudine-resistant hepatitis B virus.

  The Tohoku journal of experimental medicine 20071001

• Entecavir: new drug. Chronic hepatitis B: a last resort.

  Prescrire international 20071001

• Engineering immune therapy against hepatitis B virus.

  Hepatology research : the official journal of the Japan Society of Hepatology 20071001

• [New German and American guidelines for therapy of hepatitis B. Discrepancies and similarities].

  Medizinische Klinik (Munich, Germany : 1983) 20070915

• Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients.

  Journal of hepatology 20070901

• Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070901

• Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B.

  Journal of gastroenterology and hepatology 20070901

• Comparative cost-effectiveness of antiviral therapies in patients with chronic hepatitis B: a systematic review of economic evidence.

  Journal of gastroenterology and hepatology 20070901

• Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070901

• [Effect of initial virologic response to adefovir on the development of resistance to adefovir in lamivudine-resistant chronic hepatitis B].

  The Korean journal of hepatology 20070901

• [Therapeutic options in chronic HBV infection].

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20070901

• [Diammonium glycyrrhizinate does not affect efficacy of adefovir dipivoxil therapy in patients with HBeAg-positive chronic hepatitis B].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20070901

• [Efficacy of adefovir dipivoxil was not related to genotypes B and C of hepatitis B virus: a randomized, double-blind, multicenter clinical study].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20070901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20070901

• Prophylaxis of hepatitis B recurrence in post-liver transplantation patients with lamivudine-resistant YMDD mutant.

  Chinese medical journal 20070820

• Antiviral efficacy of adefovir dipivoxil versus lamivudine in patients with chronic hepatitis B sequentially treated with lamivudine and adefovir due to lamivudine resistance.

  World journal of gastroenterology 20070814

• Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B.

  World journal of gastroenterology 20070814

• Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.

  Antiviral research 20070801

• Does pre-treatment with lamivudine prime for adefovir resistance of hepatitis B virus infection?

  The Journal of antimicrobial chemotherapy 20070801

• Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment.

  The Journal of antimicrobial chemotherapy 20070801

• Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom.

  European journal of gastroenterology & hepatology 20070801

• Pradefovir, a liver-targeted prodrug of adefovir against HBV infection.

  Current opinion in investigational drugs (London, England : 2000) 20070801

• Customizing the management of chronic hepatitis B virus infection.

  Seminars in liver disease 20070801

• Chronic hepatitis B: a wider range of therapeutic options.

  Prescrire international 20070801

• Second tenofovir phase III study for the chronic HBV reaches primary endpoint.

  AIDS patient care and STDs 20070801

• Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection.

  Therapeutics and clinical risk management 20070801

• The acyclic nucleoside phosphonates from inception to clinical use: historical perspective.

  Antiviral research 20070701

• Hepatitis B virus reactivation in a case of Waldenstrom's macroglobulinemia treated with chemotherapy and rituximab despite adefovir prophylaxis.

  American journal of hematology 20070701

• Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir.

  Antiviral research 20070701

• Optimal duration of therapy in HBV-related cirrhosis.

  The Journal of antimicrobial chemotherapy 20070701

• Evolution of viral load and changes of polymerase and precore/core promoter sequences in lamivudine-resistant hepatitis B virus during adefovir therapy.

  Journal of medical virology 20070701

• Pre- and post-treatment predictors of the early achievement of HBeAg loss in lamivudine-resistant patients receiving adefovir therapy.

  Journal of gastroenterology and hepatology 20070701

• Appropriate use of interferon for treatment of chronic hepatitis B.

  Hepatology research : the official journal of the Japan Society of Hepatology 20070701

• Treatment of chronic hepatitis B with the combination of pegylated interferon with lamivudine.

  Hepatology research : the official journal of the Japan Society of Hepatology 20070701

• Improving outcomes for patients with chronic hepatitis B.

  Hepatology research : the official journal of the Japan Society of Hepatology 20070701

• Clinical update: hepatitis B.

  Gastroenterology & hepatology 20070701

• Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY).

  AIDS (London, England) 20070619

• HPLC method for determination of in vitro delivery through and into porcine skin of adefovir (PMEA).

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070615

• Treatment paradigms on hepatitis B e antigen-negative chronic hepatitis B patients.

  Expert opinion on investigational drugs 20070601

• Primary effusion lymphoma involving both pleural and abdominal cavities in a patient with hepatitis B virus-related liver cirrhosis.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20070601

• [An economic evaluation of different treatments for HBeAg-positive chronic hepatitis B in China].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20070601

• In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.

  Veterinary microbiology 20070516

• [Epidemiology of hepatitis B in Germany].

  Medizinische Klinik (Munich, Germany : 1983) 20070515

• Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily.

  Journal of hepatology 20070501

• Progress in the treatment of chronic hepatitis B: long-term experience with adefovir dipivoxil.

  The Journal of antimicrobial chemotherapy 20070501

• Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20070501

• Tailoring antiviral therapy in chronic hepatitis B patients with lamivudine resistance.

  Journal of hepatology 20070501

• Update on viral hepatitis: 2006.

  Current opinion in gastroenterology 20070501

• Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.

  The Annals of pharmacotherapy 20070501

• Telbivudine: a new option for the treatment of chronic hepatitis B.

  Expert opinion on biological therapy 20070501

• [Three year adefovir dipivoxil treatment for hepatitis B e antigen-positive chronic hepatitis B patients].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20070501

• Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial.

  PLoS clinical trials 20070501

• Drug resistance in antiviral treatment for infections with hepatitis B and C viruses.

  Journal of gastroenterology 20070501

• Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine.

  Journal of gastroenterology 20070501

• Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients.

  Current drug safety 20070501

• Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B.

  Virology 20070425

• Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B.

  Alimentary pharmacology & therapeutics 20070415

• Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.

  Biochemical pharmacology 20070401

• Simultaneous quantitation of the nucleotide analog adefovir, its phosphorylated anabolites and 2'-deoxyadenosine triphosphate by ion-pairing LC/MS/MS.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070401

• Hepatitis B virus resistance to adefovir in a nucleotide naive patient with chronic hepatitis B virus infection.

  The Journal of antimicrobial chemotherapy 20070401

• Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).

  Pharmaceutical research 20070401

• Characteristics of patients with chronic hepatitis-B virus infection in an urban hospital.

  Journal of the National Medical Association 20070401

• [Advances in research of hepatitis B virus resistance to adefovir].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20070401

• Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B.

  Drugs of today (Barcelona, Spain : 1998) 20070401

• Recommendations for the treatment of chronic hepatitis B infection in children.

  JPMA. The Journal of the Pakistan Medical Association 20070401

• [Recent advances in the treatment of the hepatitis HBV-related. Effectiveness and tolerability of adefovir dipivoxil].

  Recenti progressi in medicina 20070401

• [A clinical study of adefovir dipivoxil in treating lamivudine refractory HBeAg-positive chronic hepatitis B].

  Zhonghua nei ke za zhi 20070401

• [A case of chronic hepatitis B with primary adefovir resistance].

  Mikrobiyoloji bulteni 20070401

• New and emerging treatment of chronic hepatitis B.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070301

• Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20070301

• Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20070301

• Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20070301

• Improving outcomes for patients with chronic hepatitis B.

  Current gastroenterology reports 20070301

• Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer?

  Gut 20070301

• Molecular mechanisms of resistance to antiviral therapy in patients with chronic hepatitis B.

  Current molecular medicine 20070301

• Diagnosis and treatment of chronic hepatitis B: an update.

  Minerva gastroenterologica e dietologica 20070301

• Treatment of chronic hepatitis B in HIV-infected patients in 2007.

  Journal of HIV therapy 20070301

• Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.

  Yonsei medical journal 20070227

• [Drugs for hepatitis B and C infection].

  Nihon rinsho. Japanese journal of clinical medicine 20070227

• [Mechanisms of drug resistance in hepatitis viruses B and C].

  Nihon rinsho. Japanese journal of clinical medicine 20070227

• Why do we not yet have combination chemotherapy for chronic hepatitis B?

  The Medical journal of Australia 20070219

• Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir.

  Molecular pharmacology 20070201

• The management of HIV and hepatitis B coinfection.

  Current opinion in infectious diseases 20070201

• Efficacy of adefovir dipivoxil in the treatment of lamivudine-resistant hepatitis B virus genotype C infection.

  Liver international : official journal of the International Association for the Study of the Liver 20070201

• A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon-alpha-2a for the treatment of chronic hepatitis B.

  Journal of viral hepatitis 20070201

• Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B.

  Hepatology (Baltimore, Md.) 20070201

• Rescue therapy for lamivudine-resistant chronic hepatitis B: when and how?

  Hepatology (Baltimore, Md.) 20070201

• Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus.

  Hepatology research : the official journal of the Japan Society of Hepatology 20070201

• Outcomes of chronic hepatitis B infection in Oriental patients with rheumatic diseases.

  Annals of the Academy of Medicine, Singapore 20070201

• Design and synthesis of novel bis(L-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) with improved anti-HBV activity.

  Bioorganic & medicinal chemistry letters 20070115

• Antiviral therapy and resistance with hepatitis B virus infection.

  World journal of gastroenterology 20070107

• Pharmacokinetics, safety and tolerance of single- and multiple-dose adefovir dipivoxil in healthy Chinese subjects.

  British journal of clinical pharmacology 20070101

• Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines.

  The Journal of antimicrobial chemotherapy 20070101

• Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients.

  Clinical drug investigation 20070101

• Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage.

  Cancer research 20070101

• From actually toxic to highly specific--novel drugs against poxviruses.

  Virology journal 20070101

• [The rate of hepatitis B virus resistance to adefovir dipivoxil (ADV) and the evolution of hepatitis B virus in lamivudine-resistant chronic hepatitis B patients with ADV monotherapy].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20070101

• [Significance of novel HBV expression vectors in selecting antiviral drugs in clinical therapy].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20070101

• [Phenotypes and functions of dendritic cells derived from peripheral blood monocytes of chronic hepatitis B patients with different HBV DNA loads].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20070101

• [Autoimmune thrombopenia associated with hepatitis B reactivation (reverse seroconversion) after autologous hematopoietic stem cell transplantation].

  Gastroenterologie clinique et biologique 20070101

• Decompensated lamivudine-resistant hepatitis B virus-related cirrhosis treated successfully with adefovir dipivoxil allowing surgery for hepatocellular carcinoma.

  Internal medicine (Tokyo, Japan) 20070101

• Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.

  Retrovirology 20070101

• [The prophylaxis against post-liver-transplant hepatitis B re-infection].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20070101

• Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients.

  Comparative hepatology 20070101

• Treatment of HIV/HBV coinfection: clinical and virologic issues.

  AIDS reviews 20070101

• Adefovir dipivoxil monotherapy and combination therapy with lamivudine for the treatment of chronic hepatitis B in an Asian population.

  Antiviral therapy 20070101

• Hepatitis B genotypes and response to antiviral therapy: a review.

  American journal of therapeutics 20070101

• In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents.

  Antiviral therapy 20070101

• Common genotypes of Hepatitis B virus prevalent in injecting drug abusers (addicts) of North West Frontier Province of Pakistan.

  Virology journal 20070101

• Chronic hepatitis B with advanced fibrosis or cirrhosis: impact of antiviral therapy.

  Reviews in gastroenterological disorders 20070101

• Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.

  Antiviral therapy 20070101

• DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.

  Antiviral therapy 20070101

• A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment.

  Antiviral therapy 20070101

• Telbivudine.

  Drugs 20070101

• [Advances in the treatment of hepatitis B].

  Revista da Sociedade Brasileira de Medicina Tropical 20070101

• Molecular epidemiology of Hepatitis B virus genotypes in Pakistan.

  BMC infectious diseases 20070101

• Meta-analyses of FibroTest diagnostic value in chronic liver disease.

  BMC gastroenterology 20070101

• Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B.

  PharmacoEconomics 20070101

• Dynamics of HBV DNA levels, HBV mutations and biochemical parameters during antiviral therapy in a patient with HBeAg-negative chronic hepatitis B.

  Asian Pacific journal of allergy and immunology 20070101

• The association of complex liver disorders with HBV genotypes prevalent in Pakistan.

  Virology journal 20070101

• Special considerations and treatment of patients with HBV-HIV coinfection.

  Antiviral therapy 20070101

• Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.

  Acta gastro-enterologica Belgica 20070101

• The flounder organic anion transporter fOat has sequence, function, and substrate specificity similarity to both mammalian Oat1 and Oat3.

  American journal of physiology. Regulatory, integrative and comparative physiology 20061201

• Nonresponse to adefovir: host or virus dependent?

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20061201

• Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.

  Gastroenterology 20061201

• Effect of switching to tenofovir with emtricitabine in patients with chronic hepatitis B failing to respond to an adefovir-containing regimen.

  European journal of gastroenterology & hepatology 20061201

• Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection.

  Pharmacotherapy 20061201

• Experimental approaches to studies on drug metabolism and drug interactions in man: interaction of acyclic nucleoside phosphonates with human liver cytochromes P450 and flavin-containing monooxygenase 3.

  Neuro endocrinology letters 20061201

• Inhibition of human liver microsomal cytochrome P450 activities by adefovir and tenofovir.

  Xenobiotica; the fate of foreign compounds in biological systems 20061201

• [A clinical study of adefovir dipivoxil, made in China, for treatment of hepatitis B e antigen-positive patients with chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20061201

• The prevention of an expected hepatic flare in HBe negative patients after lamivudine discontinuation.

  Journal of gastrointestinal and liver diseases : JGLD 20061201

• Hepatitis B virus treatment in HIV-infected patients.

  Topics in HIV medicine : a publication of the International AIDS Society, USA 20061201

• [Resistance to adefovir in patients with chronic hepatitis B].

  The Korean journal of hepatology 20061201

• Viruses and human cancer.

  The Yale journal of biology and medicine 20061201

• The 'return' of hepatitis B.

  World journal of gastroenterology 20061128

• A novel hepatitis B virus mutation with resistance to adefovir but not to tenofovir in an HIV-hepatitis B virus-co-infected patient.

  AIDS (London, England) 20061114

• Hepatitis B in liver transplant recipients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20061101

• Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy.

  Journal of viral hepatitis 20061101

• Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.

  Hepatology (Baltimore, Md.) 20061101

• Why adefovir is not yet available in Canada.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20061101

• Treatment of lamivudine-resistant hepatitis B infection in post-renal transplant patients with adefovir dipivoxil: preliminary results.

  Transplantation proceedings 20061101

• [A double-blind, randomized, lamivudine-controlled clinical trial of DAIDING (adefovir dipivoxil) for lamivudine-resistant patients with chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20061101

• Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil.

  Gut 20061001

• Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20061001

• Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV.

  Hepatology (Baltimore, Md.) 20061001

• Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient.

  Gastroenterology 20061001

• [A case of severe skin eruption caused by lamivudine in a patient with chronic hepatitis B].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20061001

• [Managing resistance to analogue antiviral drugs in a decompensated cirrhosis patient].

  Gastroenterologie clinique et biologique 20061001

• [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].

  Gastroenterologie clinique et biologique 20061001

• [Managing lamivudine resistance in liver transplantation for hepatitis B liver disease].

  Gastroenterologie clinique et biologique 20061001

• [Impact of resistance to analogue antivirals and therapeutic strategies in situations of dialysis, kidney transplantation, vasculitis, and preemptive treatments in immunosuppressed patients].

  Gastroenterologie clinique et biologique 20061001

• [Diagnostic, clinical and therapeutic implications of viral hepatitides in HIV-infected patients].

  Enfermedades infecciosas y microbiologia clinica 20061001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20061001

• Development and validation of a sensitive LC-MS/MS method for the determination of adefovir in human serum and urine.

  Journal of pharmaceutical and biomedical analysis 20060926

• [Therapy of hepatitis B].

  Praxis 20060906

• [Therapy of hepatitis B virus infection].

  Praxis 20060906

• [Therapy of chronic hepatitis B].

  Revue medicale suisse 20060906

• Perspectives on the development of acyclic nucleotide analogs as antiviral drugs.

  Antiviral research 20060901

• Antiviral acyclic nucleoside phosphonates structure activity studies.

  Antiviral research 20060901

• Adefovir dipivoxyl for the treatment of delta-related liver cirrhosis.

  The Annals of pharmacotherapy 20060901

• Favorable outcome of liver transplantation despite a high hepatitis B virus replication: beyond the limits?

  Transplant infectious disease : an official journal of the Transplantation Society 20060901

• New developments in the treatment of chronic hepatitis B.

  Expert opinion on biological therapy 20060901

• Lamivudine treatment in patients with chronic hepatitis B and cirrhosis.

  Expert opinion on pharmacotherapy 20060901

• Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B.

  Hepatology (Baltimore, Md.) 20060901

• Evolution of multi-drug resistant hepatitis B virus during sequential therapy.

  Hepatology (Baltimore, Md.) 20060901

• Treatment alternatives for hepatitis B cirrhosis: a cost-effectiveness analysis.

  The American journal of gastroenterology 20060901

• Membrane transporter proteins: a challenge for CNS drug development.

  Dialogues in clinical neuroscience 20060901

• Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis B.

  International journal of nanomedicine 20060901

• Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agents.

  Antiviral research 20060801

• Changes in viral loads of lamivudine-resistant mutants and evolution of HBV sequences during adefovir dipivoxil therapy.

  Journal of medical virology 20060801

• A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060801

• Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.

  Hepatology (Baltimore, Md.) 20060801

• Treatment of chronic hepatitis B.

  Nature clinical practice. Gastroenterology & hepatology 20060801

• Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

  Health technology assessment (Winchester, England) 20060801

• Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20060801

• Hepatitis B virus with primary resistance to adefovir.

  The New England journal of medicine 20060720

• Tubular transporters and clearance of adefovir.

  European journal of pharmacology 20060701

• A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B.

  Hepatology (Baltimore, Md.) 20060701

• Long-term results of liver transplant in patients with chronic viral hepatitis-related liver disease in Singapore.

  Singapore medical journal 20060701

• Nephrotoxicity as a complication of antiretroviral therapy.

  Advances in chronic kidney disease 20060701

• Chronic Hepatitis B and C--current treatment and future therapeutic prospects.

  Wiener medizinische Wochenschrift (1946) 20060701

• Antiviral options for the treatment of chronic hepatitis B.

  The Journal of antimicrobial chemotherapy 20060601

• Five-year follow-up of a hepatitis B virus-positive recipient of hepatitis B surface antigen-positive living donor liver graft.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20060601

• Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.

  Hepatology (Baltimore, Md.) 20060601

• American Association for Cancer Research--97th annual meeting.

  IDrugs : the investigational drugs journal 20060601

• Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?

  The Netherlands journal of medicine 20060601

• [To evaluate treatments of chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20060601

• [Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy in acute exacerbation after viral breakthrough during lamivudine therapy in chronic hepatitis B].

  The Korean journal of hepatology 20060601

• Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants.

  Journal of viral hepatitis 20060601

• Hepatitis B: the pathway to recovery through treatment.

  Gastroenterology clinics of North America 20060601

• In vivo effects of antiviral acyclic nucleoside phosphonate 9-[2-(phosphonomethoxy)ethyl]adenine (adefovir) on cytochrome P450 system of rat liver microsomes.

  Journal of biomedical science 20060501

• Entecavir: a new treatment option for chronic hepatitis B.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20060501

• First report of genotypic resistance to adefovir in chronic HBV in the Republic of Ireland.

  The Journal of antimicrobial chemotherapy 20060501

• Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20060501

• Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20060501

• Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation.

  The Annals of thoracic surgery 20060501

• Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment.

  Seminars in liver disease 20060501

• Hepatitis B virus-related cirrhosis: natural history and treatment.

  Seminars in liver disease 20060501

• Antiviral drug resistance: clinical consequences and molecular aspects.

  Seminars in liver disease 20060501

• Current issues and future directions in treatment.

  Seminars in liver disease 20060501

• [The change of HBV nucleotide sequence during Adefovir dipivoxil treatment].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20060501

• [The use of nucleotide analogues in treating patients with chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20060501

• [Problems of and strategies in nucleotide analogues therapy for chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20060501

• [Successful lamivudine therapy for chronic hepatitis B in the family].

  Vojnosanitetski pregled 20060501

• Management of drug-resistant chronic hepatitis B.

  Clinics in liver disease 20060501

• Variant of hepatitis B virus with primary resistance to adefovir.

  The New England journal of medicine 20060427

• Review article: hepatitis B and liver transplantation.

  Alimentary pharmacology & therapeutics 20060415

• [Reactivation of hepatitis B treated with adefovir after infliximab administration].

  Medicina clinica 20060415

• Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20060401

• Personal view: the management of chronic hepatitis B infection.

  Alimentary pharmacology & therapeutics 20060401

• Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis.

  Journal of viral hepatitis 20060401

• Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation.

  Bone marrow transplantation 20060301

• Adefovir dipivoxil-associated thrombocytopenia in a patient with chronic hepatitis B.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060301

• Assessment and management of chronic hepatitis B.

  Infectious disease clinics of North America 20060301

• Effects of nucleoside analogues on liver regeneration 70% partially hepatectomized rats.

  Transplantation proceedings 20060301

• Medical therapy of patients affected by HBeAg-negative chronic hepatitis B.

  Minerva gastroenterologica e dietologica 20060301

• Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B.

  Journal of gastroenterology 20060301

• Virologic response and resistance to adefovir in patients with chronic hepatitis B.

  Journal of hepatology 20060201

• Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B.

  Alimentary pharmacology & therapeutics 20060201

• Therapy of hepatitis B -- viral suppression or eradication?

  Hepatology (Baltimore, Md.) 20060201

• [Lamivudine and adefovir resistance in a patient with HBeAg negative chronic hepatitis B].

  Gastroenterologia y hepatologia 20060201

• Chronic hepatitis B: a critical appraisal of current approaches to therapy.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060201

• Management of chronic hepatitis B virus infection: a new era of disease control.

  Internal medicine journal 20060201

• Combination therapy for chronic hepatitis B: a one-two knockout punch, or a swing and a miss?

  Gastroenterology 20060201

• Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20060201

• Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20060201

• Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replication.

  Scandinavian journal of gastroenterology 20060201

• [New virologic tests and their application in management of chronic hepatitis B].

  Presse medicale (Paris, France : 1983) 20060201

• [Treatment of chronic hepatitis B].

  Presse medicale (Paris, France : 1983) 20060201

• [Liver transplantation for complications of hepatitis B].

  Presse medicale (Paris, France : 1983) 20060201

• Detecting hepatitis B surface antigen mutants.

  Emerging infectious diseases 20060201

• HepDirect prodrugs for targeting nucleotide-based antiviral drugs to the liver.

  Current opinion in investigational drugs (London, England : 2000) 20060201

• Potency of stampidine against multi-nucleoside reverse transcriptase inhibitor resistant human immunodeficiency viruses.

  Arzneimittel-Forschung 20060201

• [Hepatology].

  Revue medicale suisse 20060118

• Utilization of a liver allograft from a hepatitis B surface antigen positive donor.

  Transplantation 20060115

• Purine P1 receptor-dependent immunostimulatory effects of antiviral acyclic analogues of adenine and 2,6-diaminopurine.

  European journal of pharmacology 20060113

• Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060102

• Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1.

  Journal of hepatology 20060101

• Treatment of lamivudine-resistant hepatitis B in HIV-infected persons: is adefovir dipivoxil the answer?

  Journal of hepatology 20060101

• Assessment of treatment efficacy in HBV infection and disease.

  Journal of hepatology 20060101

• Treatment algorithm for chronic hepatitis B in HIV-infected patients.

  Journal of hepatology 20060101

• Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their management.

  Journal of hepatology 20060101

• Treatment options in HBV.

  Journal of hepatology 20060101

• Antiviral hepatitis and antiretroviral drug interactions.

  Journal of hepatology 20060101

• The benefits of adefovir dipivoxil for HBeAg-negative chronic hepatitis B did not persist after discontinuation of treatment.

  ACP journal club 20060101

• The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses.

  Cerebrospinal fluid research 20060101

• Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant.

  Comparative hepatology 20060101

• Emerging therapeutics for chronic hepatitis B.

  Annual review of medicine 20060101

• Introduction to chronic hepatitis B infection.

  The American journal of gastroenterology 20060101

• Therapeutic options for chronic hepatitis B: considerations and controversies.

  The American journal of gastroenterology 20060101

• Topotecan is a substrate for multidrug resistance associated protein 4.

  Current drug metabolism 20060101

• Hepatitis B virus genotypes and response to antiviral therapy.

  Clinical laboratory 20060101

• Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues.

  Annals of clinical microbiology and antimicrobials 20060101

• Recent advances in antiviral agents: antiviral drug discovery for hepatitis viruses.

  Current pharmaceutical design 20060101

• Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection.

  International journal of medical sciences 20060101

• Hepatitis B virus mutations associated with antiviral therapy.

  Journal of medical virology 20060101

• In vitro comparison of antiviral drugs against feline herpesvirus 1.

  BMC veterinary research 20060101

• Current treatment of chronic hepatitis B.

  Archives of Iranian medicine 20060101

• Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

  Archives of Iranian medicine 20060101

• Established and emerging therapies for the treatment of viral hepatitis.

  Digestive diseases (Basel, Switzerland) 20060101

• [Entecavir--close perspective for using it].

  Przeglad epidemiologiczny 20060101

• Cationic polyamines inhibit anthrax lethal factor protease.

  BMC pharmacology 20060101

• Nucleoside analogs as anti-HBV agents.

  Current topics in medicinal chemistry 20060101

• Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi.

  BMC gastroenterology 20060101

• Chronic hepatitis B--who should be treated?

  MedGenMed : Medscape general medicine 20060101

• [Treatment of viral hepatitis (I). Treatment of chronic hepatitis B].

  Enfermedades infecciosas y microbiologia clinica 20060101

• Temporary HBV resolution in an HIV-coinfected patient during HBV-directed combination therapy followed by relapse of HBV.

  Antiviral therapy 20060101

• Natural course, therapeutic options and economic evaluation of therapies for chronic hepatitis B.

  Drugs 20060101

• Treating chronic hepatitis B: today and tomorrow.

  Current medicinal chemistry 20060101

• Prevention of hepatitis B virus recurrence after liver transplantation.

  Clinical transplantation 20060101

• Abacavir-induced reversible Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome.

  Journal of postgraduate medicine 20060101

• [Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20060101

• Post-exposure prophylaxis for SIV revisited: animal model for HIV prevention.

  AIDS research and therapy 20060101

• Successful treatment with adefovir of one patient whose cryoglobulinemic vasculitis relapsed under lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations.

  Internal medicine (Tokyo, Japan) 20060101

• Report from the 2nd International Workshop on HIV and Hepatitis Co-Infection, January 12-14, 2006, Amsterdam, Netherlands. Tenofovir or adefovir for hepatitis B.

  TreatmentUpdate 20060101

• A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B.

  Antiviral therapy 20060101

• Unusual selection of rtA181V HBV mutants cross-resistant to adefovir following prolonged lamivudine monotherapy: report of two cases.

  Antiviral therapy 20060101

• Virological response and incidence of adefovir resistance in lamivudine-resistant patients treated with adefovir dipivoxil.

  Antiviral therapy 20060101

• Pegylated interferons for the treatment of chronic hepatitis B.

  Recent patents on anti-infective drug discovery 20060101

• cycloSal-PMEA and cycloAmb-PMEA: potentially new phosphonate prodrugs based on the cycloSal-pronucleotide approach.

  Journal of medicinal chemistry 20051215

• Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation.

  Journal of hepatology 20051201

• Resistance to adefovir: a new challenge in the treatment of chronic hepatitis B.

  Journal of hepatology 20051201

• Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine.

  Hepatology (Baltimore, Md.) 20051201

• Complications in treating chronic hepatitis B in patients with HIV.

  Expert opinion on pharmacotherapy 20051201

• Hepatitis B virus infection: current status.

  The American journal of medicine 20051201

• [Safety and tolerance study of single oral dose of adefovir dipivoxil tablets in healthy volunteers].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20051201

• The current management of HBV drug resistance.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20051201

• Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20051201

• Cytotoxicity of pivoxil esters of antiviral acyclic nucleoside phosphonates: adefovir dipivoxil versus adefovir.

  Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20051201

• [Drug therapy in chronic liver disease].

  Praxis 20051130

• Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir.

  AIDS (London, England) 20051118

• Hepatitis B and liver transplantation.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051115

• Cost-effectiveness in hepatitis B.

  Annals of internal medicine 20051115

• Heart transplantation in patients with chronic hepatitis B: clinical evolution, molecular analysis, and effect of treatment.

  Transplantation 20051115

• Human multidrug resistance associated protein 4 confers resistance to camptothecins.

  Pharmaceutical research 20051101

• Pharmacokinetics of pradefovir and PMEA in healthy volunteers after oral dosing of pradefovir.

  Journal of clinical pharmacology 20051101

• Acyclic nucleoside phosphonates: a key class of antiviral drugs.

  Nature reviews. Drug discovery 20051101

• Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20051101

• A review of entecavir in the treatment of chronic hepatitis B infection.

  Current medical research and opinion 20051101

• Clinical and virological effects during two years of ongoing adefovir dipivoxil in the treatment of lamivudine-resistant chronic hepatitis B infection.

  Transplantation proceedings 20051101

• Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus.

  Transplantation proceedings 20051101

• [Tubular transporters OAT1 and MRP2 and clearance of adefovir].

  Nephrologie & therapeutique 20051101

• Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency.

  Transplantation 20051027

• Interferon-alpha plus lamivudine vs lamivudine reduces breakthroughs, but does not affect sustained response in HBeAg negative chronic hepatitis B.

  World journal of gastroenterology 20051007

• Nucleotide analogs as novel anti-hepatitis B virus agents.

  Current opinion in pharmacology 20051001

• Hepatitis B in children: complexities in management.

  Pediatric transplantation 20051001

• Clevudine for the treatment of chronic hepatitis B virus infection.

  Expert opinion on investigational drugs 20051001

• Adefovir dipivoxil alone or in combination with ongoing lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus.

  Journal of Korean medical science 20051001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20051001

• [Treatment response to lamivudine in chronic hepatitis B patients].

  Anales de medicina interna (Madrid, Spain : 1984) 20051001

• [New aspect in the treatment of chronic hepatis B].

  Revue medicale suisse 20050907

• [Clinical outcomes after discontinuation of Lamivudine in chronic hepatitis B patients with Lamivudine resistant HBV mutant].

  The Korean journal of hepatology 20050901

• [Adefovir dipivoxil in treatment of decompensated liver cirrhosis patients with YMDD mutation].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20050901

• Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6).

  The Journal of pharmacology and experimental therapeutics 20050801

• Viral kinetics in patients with lamivudine-resistant hepatitis B during adefovir-lamivudine combination therapy.

  Journal of hepatology 20050801

• Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.

  Journal of hepatology 20050801

• The risk of adefovir monotherapy in human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infected patients.

  Journal of hepatology 20050801

• Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.

  Journal of hepatology 20050801

• Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration.

  Journal of clinical pharmacology 20050801

• Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.

  The Journal of general virology 20050801

• Managing hepatitis B coinfection in HIV-infected patients.

  Current HIV/AIDS reports 20050801

• Peginterferon-alpha2a (40 kDa) (Pegasys) for hepatitis B.

  Expert review of anti-infective therapy 20050801

• [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20050801

• Understanding hepatitis B.

  The Journal of the Association of Physicians of India 20050801

• Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.

  Transplant international : official journal of the European Society for Organ Transplantation 20050701

• Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine.

  Hepatology (Baltimore, Md.) 20050701

• Reactivation of viral replication after replacement of tenofovir by adefovir.

  Hepatology (Baltimore, Md.) 20050701

• Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20050701

• Treatment of chronic hepatitis B.

  Journal of viral hepatitis 20050701

• Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis.

  Journal of viral hepatitis 20050701

• Peginterferon-alpha 2a for the treatment of hepatitis B infection.

  Expert opinion on pharmacotherapy 20050701

• Chronic hepatitis B--treatment with nucleoside analogues.

  The Medical journal of Malaysia 20050701

• Treatment of chronic hepatitis B in HIV co-infected patients.

  The Medical journal of Malaysia 20050701

• Clinical and virological response to adefovir dipovixil for lamivudine-resistant HBeAg-negative hepatitis B.

  The new microbiologica 20050701

• Novel delivery methods for treatment of viral hepatitis: an update.

  Expert opinion on drug delivery 20050701

• Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

  The New England journal of medicine 20050630

• The maze of treatments for hepatitis B.

  The New England journal of medicine 20050630

• Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.

  Hepatology (Baltimore, Md.) 20050601

• Management of patients co-infected with hepatitis B virus and HIV.

  The Lancet. Infectious diseases 20050601

• [Efficacy and safety of adefovir dipivoxil in patients with decompensated liver cirrhosis with Lamivudine resistance compared to patients with compensated liver disease].

  The Korean journal of hepatology 20050601

• [Clinical and virologic characteristics and treatment for chronic hepatitis B: relation with HBV genotypes].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20050601

• Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment.

  Journal of gastroenterology 20050601

• Summaries for patients. Antiviral regimens for chronic hepatitis B virus infection.

  Annals of internal medicine 20050517

• Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis.

  Annals of internal medicine 20050517

• Assessing the benefits and costs of new therapies for hepatitis B virus infection.

  Annals of internal medicine 20050517

• [Influence of nucleoside analogues resistance on anti-HBV treatment].

  Zhonghua yi xue za zhi 20050511

• Update on viral hepatitis in 2004.

  Current opinion in gastroenterology 20050501

• Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20050501

• Antiviral drug-induced nephrotoxicity.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20050501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050501

• [Management of chronic hepatitis B].

  Praxis 20050420

• Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration.

  PLoS medicine 20050401

• Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1).

  Pharmacogenetics and genomics 20050401

• [Chronic hepatitis B: which patients should be treated and how?].

  Gastroenterologie clinique et biologique 20050401

• Treatment with adefovir dipivoxil in a renal transplant patient with renal insufficiency and lamivudine-resistant hepatitis B infection.

  Transplantation proceedings 20050401

• Adefovir dipivoxil therapy in liver transplant recipients with lamivudine-resistant hepatitis B virus.

  Transplantation proceedings 20050401

• [Treatment of chronic hepatitis B].

  La Revue du praticien 20050331

• Adefovir dipivoxil added to ongoing lamivudine therapy in patients with lamivudine-resistant hepatitis B e antigen-negative chronic hepatitis B.

  Alimentary pharmacology & therapeutics 20050301

• Current and future treatment of chronic hepatitis B.

  Minerva gastroenterologica e dietologica 20050301

• [Therapeutic effect of adefovir dipivoxil on recurrent or de novo infection of hepatitis B virus after liver transplantation: a preliminary report].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20050301

• [Advances in treatment of chronic hepatitis B].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20050301

• Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.

  AIDS (London, England) 20050218

• Liver-targeted drug delivery using HepDirect prodrugs.

  The Journal of pharmacology and experimental therapeutics 20050201

• Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure.

  Journal of hepatology 20050201

• Adefovir dipivoxil for chemotherapy-induced activation of hepatitis B virus infection.

  The New England journal of medicine 20050120

• [When and how to treat hepatitis B and C?].

  Revue medicale suisse 20050119

• Management of hepatitis B in liver transplant patients.

  Journal of clinical gastroenterology 20050101

• Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes.

  Journal of hepatology 20050101

• Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients.

  Journal of viral hepatitis 20050101

• [Lamivudine for the treatment of patients with chronic hepatitis with negative hepatitis B AgHbe].

  Anales de medicina interna (Madrid, Spain : 1984) 20050101

• Viral hepatitis and hepatocellular carcinoma.

  World journal of surgical oncology 20050101

• Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of adefovir in human plasma.

  Rapid communications in mass spectrometry : RCM 20050101

• Adefovir dipivoxil: focus on its use in the treatment of chronic hepatitis B.

  Reviews in gastroenterological disorders 20050101

• Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosides.

  Antiviral chemistry & chemotherapy 20050101

• Drugs in development for hepatitis B.

  Drugs 20050101

• Current treatment of chronic hepatitis B: benefits and limitations.

  Seminars in liver disease 20050101

• Management of HBV/HIV-coinfected Patients.

  Seminars in liver disease 20050101

• Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV.

  Antiviral therapy 20050101

• Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection.

  Annals of clinical microbiology and antimicrobials 20050101

• Determination of adefovir in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study.

  Rapid communications in mass spectrometry : RCM 20050101

• Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.

  Nucleosides, nucleotides & nucleic acids 20050101

• [Treatment of the side effects of antiviral therapy].

  Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20050101

• [Chronic hepatitis B: from old braids and new brooms].

  Krankenpflege Journal 20050101

• Diagnosis and treatment of viral liver fibrosis.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20050101

• Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.

  Journal of gastroenterology and hepatology 20041201

• Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection.

  Hepatology (Baltimore, Md.) 20041201

• Entecavir for the treatment of chronic hepatitis B.

  Expert review of anti-infective therapy 20041201

• The management of chronic viral hepatitis: a Canadian consensus conference 2004.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20041201

• Review article: Nucleoside analogues for the treatment of chronic hepatitis B.

  Alimentary pharmacology & therapeutics 20041201

• Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.

  Journal of gastroenterology and hepatology 20041201

• Drug-induced renal failure in the ICU.

  The International journal of artificial organs 20041201

• Management of hepatitis B patients with antiviral resistance.

  Antiviral therapy 20041201

• [Liver transplantation for hepatitis B].

  Vnitrni lekarstvi 20041201

• Diagnosis and treatment of chronic hepatitis B.

  Minerva gastroenterologica e dietologica 20041201

• Drug insight: Nucleoside and nucleotide analog inhibitors for hepatitis B.

  Nature clinical practice. Gastroenterology & hepatology 20041201

• Multidrug resistance protein 4 (ABCC4)-mediated ATP hydrolysis: effect of transport substrates and characterization of the post-hydrolysis transition state.

  The Journal of biological chemistry 20041119

• Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment.

  AIDS (London, England) 20041119

• Effective metabolism and long intracellular half life of the anti-hepatitis B agent adefovir in hepatic cells.

  Biochemical pharmacology 20041101

• Treatments for hepatitis B.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041101

• Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20041101

• Adefovir dipivoxil in chronic hepatitis B infection.

  Expert opinion on pharmacotherapy 20041101

• [Advances in the diagnosis and treatment of the infection by the hepatitis B virus].

  Enfermedades infecciosas y microbiologia clinica 20041101

• Emerging treatments in chronic hepatitis B.

  Expert opinion on emerging drugs 20041101

• Outcomes of liver transplantation for hepatitis B: a single-center study of 35 patients.

  Transplantation proceedings 20041101

• Adefovir treatment in posttransplant hepatitis B virus infection resistant to lamivudine plus hepatitis B virus immunoglobulin.

  Transplantation proceedings 20041101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20041101

• Remofovir mesylate: a prodrug of PMEA with improved liver-targeting and safety in rats and monkeys.

  Antiviral chemistry & chemotherapy 20041101

• Advances in hepatitis B and C.

  Current opinion in infectious diseases 20041001

• Evolving strategies to prevent HBV recurrence.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20041001

• Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro.

  Antimicrobial agents and chemotherapy 20041001

• Treatment of chronic hepatitis B: who to treat, what to use, and for how long?

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20041001

• Current therapies for chronic hepatitis B virus infection.

  Expert review of anti-infective therapy 20041001

• [An attempt to approach an optional therapeutic regimen for chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20041001

• Influence of mutations in the hepatitis B virus genome on virus replication and drug resistance--implications for novel antiviral strategies.

  Current medicinal chemistry 20041001

• Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant.

  Transplantation proceedings 20041001

• Prevention of hepatitis B virus reinfection after orthotopic liver transplantation.

  Transplantation proceedings 20041001

• 6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity.

  Nucleosides, nucleotides & nucleic acids 20041001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20041001

• A novel pattern (sW195a) in surface gene of HBV DNA due to YSDD (L180M plus M204S) mutation selected during lamivudine therapy and successful treatment with adefovir dipivoxil.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20040901

• Antiviral therapy for treatment-naïve hepatitis B virus patients.

  Gastroenterology clinics of North America 20040901

• Management of chronic hepatitis B in treatment-experienced patients.

  Gastroenterology clinics of North America 20040901

• Treatment of hepatitis B virus infection in patients coinfected with HIV.

  Gastroenterology clinics of North America 20040901

• Antiviral therapy in patients with chronic hepatitis B and cirrhosis.

  Gastroenterology clinics of North America 20040901

• Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies.

  Kidney international 20040901

• [Active prevention and treatment of superinfection with HBV, HCV and HIV].

  Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 20040901

• Adefovir dipivoxil: review of a novel acyclic nucleoside analogue.

  International journal of clinical practice 20040901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040901

• Molecular mechanisms of adefovir sensitivity and resistance in HBV polymerase mutants: a molecular dynamics study.

  Bioorganic & medicinal chemistry letters 20040816

• Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.

  Antiviral research 20040801

• Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.

  The American journal of gastroenterology 20040801

• Current antiviral therapy for chronic hepatitis B.

  Journal of Korean medical science 20040801

• Prevention of hepatitis B virus reinfection after orthotopic liver transplantation.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20040801

• [Antiviral treatment of chronic hepatitis B with adefovir dipivoxil].

  Nihon rinsho. Japanese journal of clinical medicine 20040801

• [Management of hepatitis B].

  Therapeutische Umschau. Revue therapeutique 20040801

• Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection.

  Expert review of anti-infective therapy 20040801

• [Hepatitis B (acute and chronic)].

  Praxis 20040728

• Management of the coinfected patient: human immunodeficiency virus/hepatitis B and human immunodeficiency virus/hepatitis C.

  The American journal of the medical sciences 20040701

• Synthesis and antiviral activity of 2,4-diamino-5-cyano-6-[2-(phosphonomethoxy)ethoxy]pyrimidine and related compounds.

  Bioorganic & medicinal chemistry 20040615

• Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia.

  The Journal of pharmacology and experimental therapeutics 20040601

• Antiviral drugs in current clinical use.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20040601

• Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.

  Antiviral research 20040601

• Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis.

  Clinical transplantation 20040601

• Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents.

  Antimicrobial agents and chemotherapy 20040601

• Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

  Gastroenterology 20040601

• In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.

  Antiviral therapy 20040601

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040601

• [New approaches in the treatment of hepatitis B].

  Deutsche medizinische Wochenschrift (1946) 20040521

• Fanconi's syndrome in HIV+ adults: report of three cases and literature review.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040501

• [A case of liver cirrhosis B resistant to lamivudine showing the clinical effect of adefovir dipivoxil].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20040501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040501

• Liver transplant and recurrent disease.

  Clinics in liver disease 20040501

• Viral hepatitis in 2003.

  Current opinion in gastroenterology 20040501

• [Determination of adefovir dipivoxil and its degradation products by reversed-phase high performance liquid chromatography].

  Se pu = Chinese journal of chromatography 20040501

• Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver.

  Journal of the American Chemical Society 20040428

• [Progress in the treatment of hepatitis B and C co-infection in HIV patients].

  MMW Fortschritte der Medizin 20040426

• Ultra sensitive method for the determination of 9-(2-phosphonylmethoxyethyl)adenine in human serum by liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040425

• Adefovir dipivoxil in the treatment of chronic hepatitis B.

  The Annals of pharmacotherapy 20040401

• Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.

  The Journal of infectious diseases 20040401

• Fibrosing cholestatic hepatitis secondary to precore/core promoter hepatitis B variant with lamivudine resistance: successful retransplantation with combination adefovir dipivoxil and hepatitis B immunoglobulin.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20040401

• Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations.

  Antiviral therapy 20040401

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040401

• [Subjective literature review: adefovir-dipivoxil].

  Medecine et maladies infectieuses 20040401

• Metal ion complexes of antivirally active nucleotide analogues. Conclusions regarding their biological action.

  Chemical Society reviews 20040330

• Antiretroviral therapy and HIV/hepatitis B virus coinfection.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040301

• Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.

  Journal of viral hepatitis 20040301

• Interfering with capsid formation: a practicable antiviral strategy against hepatitis B virus?

  Hepatology (Baltimore, Md.) 20040301

• Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040301

• Management of chronic hepatitis B in the HIV-infected patient.

  The AIDS reader 20040301

• [Adefovir dipivoxil--a further step in the control of chronic viral hepatitis B. There is still a long way to go].

  Vnitrni lekarstvi 20040301

• [Adefovir dipivoxil is a new drug for treatment of chronic hepatitis B].

  Vnitrni lekarstvi 20040301

• Therapeutic advances in chronic hepatitis B.

  Journal of gastroenterology and hepatology 20040301

• In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?

  Antiviral research 20040301

• Favourable outcome of adefovir-dipivoxil treatment in acute de novo hepatitis B after liver transplantation.

  Transplantation 20040215

• [Update in the treatment of chronic hepatitis B].

  Gastroenterologia y hepatologia 20040201

• The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIV.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040201

• [Prevention and therapy of viral hepatitis].

  Der Internist 20040201

• Rearrangement process occurring in the fragmentation of adefovir derivatives.

  Journal of mass spectrometry : JMS 20040201

• A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040201

• Novel treatment options for hepatitis B virus infection.

  Current opinion in investigational drugs (London, England : 2000) 20040201

• Adefovir dipivoxil: new preparation. A third-line option in chronic hepatitis B.

  Prescrire international 20040201

• Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains.

  Digestive diseases and sciences 20040201

• In vitro antiviral susceptibility of full-length clinical hepatitis B virus isolates cloned with a novel expression vector.

  Antiviral research 20040101

• Review article: current management of chronic hepatitis B.

  Alimentary pharmacology & therapeutics 20040101

• Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.

  Gastroenterology 20040101

• Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

  Gastroenterology 20040101

• Rescue therapy for drug resistant hepatitis B: another argument for combination chemotherapy?

  Gastroenterology 20040101

• Hepatitis B.

  American family physician 20040101

• Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy.

  Journal of viral hepatitis 20040101

• [Adefovir dipivoxil-A new drug for hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20040101

• Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.

  Zeitschrift fur Gastroenterologie 20040101

• Searching for chronic hepatitis B patients in a low prevalence area--role of racial origin.

  BMC family practice 20040101

• Molecular virology of hepatitis B virus.

  Seminars in liver disease 20040101

• Hepatitis B virus kinetics and mathematical modeling.

  Seminars in liver disease 20040101

• Treatment of patients with chronic hepatitis B with adefovir dipivoxil.

  Seminars in liver disease 20040101

• Treatment with interferons (including pegylated interferons) in patients with hepatitis B.

  Seminars in liver disease 20040101

• Management of hepatitis B in liver transplantation patients.

  Seminars in liver disease 20040101

• Practical management of chronic hepatitis B infection.

  Seminars in liver disease 20040101

• The role of interferon therapy in hepatitis B.

  MedGenMed : Medscape general medicine 20040101

• Treatment of chronic hepatitis B: from research to clinical practice via the consensus conferences.

  Current pharmaceutical design 20040101

• Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine.

  BMC infectious diseases 20040101

• Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.

  Seminars in liver disease 20040101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040101

• [Treatment of chronic hepatitis B virus infection].

  Anales del sistema sanitario de Navarra 20040101

• [Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].

  Anales del sistema sanitario de Navarra 20040101

• [Safety and efficacy of of adefovir dipivoxil in the treatment of patients with chronic hepatitis B-related liver disease].

  Gastroenterologia y hepatologia 20040101

• Adefovir dipivoxil for treatment of breakthrough hepatitis caused by lamivudine-resistant mutants of hepatitis B virus.

  Intervirology 20040101

• Treatment of chronic viral hepatitis.

  Best practice & research. Clinical gastroenterology 20040101

• [Treatment and prevention of viral hepatitis].

  Lijecnicki vjesnik 20040101

• The management of chronic viral hepatitis: A Canadian consensus conference 2004.

  The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 20040101

• Viral hepatitis B.

  Lancet (London, England) 20031220

• [New antiviral agent. Hepatitis B therapy with slight resistance risk].

  MMW Fortschritte der Medizin 20031218

• Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031215

• Adefovir (Hepsera) for chronic hepatitis B infection.

  American family physician 20031215

• Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient.

  Journal of hepatology 20031201

• Chronic viral hepatitis: always be current!

  Pediatrics in review 20031201

• Treatment of pre- and post-liver transplantation HBV infection: Should we aim at combination therapy?

  Hepatology (Baltimore, Md.) 20031201

• Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes.

  Hepatology (Baltimore, Md.) 20031201

• Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients.

  Hepatology (Baltimore, Md.) 20031201

• Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?

  Hepatology (Baltimore, Md.) 20031201

• [Nucleoside analogues resistance in the treatment of chronic hepatitis B virus infection].

  La Revue de medecine interne 20031201

• Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection.

  Clinical therapeutics 20031201

• Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation.

  Clinical transplantation 20031201

• A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.

  Antiviral therapy 20031201

• 5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity.

  Journal of medicinal chemistry 20031106

• Cytostatic activity of antiviral acyclic nucleoside phosphonates in rodent lymphocytes.

  Toxicology and applied pharmacology 20031101

• [Application and efficacy of adefovir dipivoxil in hepatitis B virus-associated chronic liver diseases].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20031101

• [Adefovir].

  Revue de l'infirmiere 20031101

• Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure.

  Transplantation 20031027

• Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates.

  The Journal of infectious diseases 20031001

• Current pharmacotherapy for the treatment of chronic hepatitis B.

  Expert opinion on pharmacotherapy 20031001

• Treatment of hepatitis B reinfection after liver transplantation.

  Minerva chirurgica 20031001

• Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions.

  Antiviral research 20031001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20031001

• Recent studies of adefovir dipivoxil for hepatitis B.

  Journal of pediatric gastroenterology and nutrition 20030901

• Early detection of hepatitis B drug resistance: implications for patient management.

  Expert review of molecular diagnostics 20030901

• Management of hepatitis B and C in HIV co-infected patients.

  Journal of acquired immune deficiency syndromes (1999) 20030901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20030901

• Management of chronic hepatitis B in an HIV-positive patient with 3TC-resistant hepatitis B virus.

  AIDS patient care and STDs 20030901

• Treatment modalities for hepatitis B viral infection and resistance to antiviral therapy.

  Panminerva medica 20030901

• [Hepatitis: associated diseases. Risk groups -- prevention -- treatment].

  Praxis 20030813

• MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine.

  The Journal of biological chemistry 20030808

• Agents in clinical development for the treatment of chronic hepatitis B.

  Expert opinion on investigational drugs 20030801

• Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.

  Gastroenterology 20030801

• Evaluation of susceptibility of human herpesvirus 8 to antiviral drugs by quantitative real-time PCR.

  Journal of clinical microbiology 20030801

• Hepatitis B reactivation in patients positive for hepatitis B surface antigen undergoing autologous hematopoietic cell transplantation.

  Leukemia & lymphoma 20030801

• Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudine.

  Transplantation proceedings 20030801

• Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant period.

  Clinics in liver disease 20030801

• [New option for successful therapy of chronic hepatitis B].

  Deutsche medizinische Wochenschrift (1946) 20030711

• Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.

  Antimicrobial agents and chemotherapy 20030701

• Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B.

  Hepatology (Baltimore, Md.) 20030701

• Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.

  Gastroenterology 20030701

• Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1.

  Gastroenterology 20030701

• Slowing the progression of chronic hepatitis B. Early antiviral therapy can help minimize complications.

  Postgraduate medicine 20030701

• The acyclic nucleoside phosphonate analogues, adefovir, tenofovir and PMEDAP, efficiently eliminate banana streak virus from banana (Musa spp.).

  Antiviral research 20030701

• Adefovir dipivoxil for hepatitis B e antigen-positive chronic hepatitis B.

  The New England journal of medicine 20030612

• [The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too].

  MMW Fortschritte der Medizin 20030612

• Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity.

  The American journal of the medical sciences 20030601

• Antiviral Research--16th Annual International Conference. Satellite symposium: clinical update on antiviral drugs. 27 April-1 May 2003, Savannah, GA, USA.

  IDrugs : the investigational drugs journal 20030601

• Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections.

  Expert review of anti-infective therapy 20030601

• Once-a-day highly active antiretroviral therapy: a systematic review.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030501

• Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks.

  Antiviral research 20030501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20030501

• [Viral hepatitis B/C and HIV. Therapy of double infections].

  MMW Fortschritte der Medizin 20030428

• Unsuccessful rescue therapy with adefovir dipivoxil for lamivudine resistant HBV in a patient with liver failure.

  Gut 20030401

• Hepatitis B virus: old, new and future approaches to antiviral treatment.

  The Journal of antimicrobial chemotherapy 20030401

• Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapy.

  The Journal of infectious diseases 20030401

• Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030305

• Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.

  Journal of hepatology 20030301

• Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20030301

• Current and future antiviral agents for chronic hepatitis B.

  The Journal of antimicrobial chemotherapy 20030301

• Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

  The New England journal of medicine 20030227

• Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

  The New England journal of medicine 20030227

• Suppressing hepatitis B without resistance--so far, so good.

  The New England journal of medicine 20030227

• Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids.

  Science (New York, N.Y.) 20030207

• Predominance of pre-S1 mutated hepatitis B virus in a patient following treatment with adefovir dipivoxil.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20030201

• Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20030201

• Treatment of HBeAg-negative chronic hepatitis B.

  Seminars in liver disease 20030201

• Management of patients with decompensated HBV cirrhosis.

  Seminars in liver disease 20030201

• Adefovir dipivoxil.

  Drugs of today (Barcelona, Spain : 1998) 20030201

• [Antiviral therapy for chronic viral hepatitis B and C].

  Nihon rinsho. Japanese journal of clinical medicine 20030201

• [Determination of adefovir in monkey plasma by liquid chromatography-tandem mass spectrometry].

  Yao xue xue bao = Acta pharmaceutica Sinica 20030201

• Management of chronic hepatitis B virus infection in remote-dwelling Aboriginals and Torres Strait Islanders: an update for primary healthcare providers.

  The Medical journal of Australia 20030120

• Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro.

  Hepatology (Baltimore, Md.) 20030101

• Comparative effects of adefovir and selected nucleoside inhibitors of hepatitis B virus DNA polymerase on mitochondrial DNA in liver and skeletal muscle cells.

  Journal of viral hepatitis 20030101

• Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections.

  Antiviral research 20030101

• In vitro activity of potential anti-poxvirus agents.

  Antiviral research 20030101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20030101

• HIV and hepatitis B virus: options for managing coinfection.

  Topics in HIV medicine : a publication of the International AIDS Society, USA 20030101

• Treatment of chronic hepatitis B: current challenges and future directions.

  Reviews in medical virology 20030101

• Adefovir dipivoxil: a review of its use in chronic hepatitis B.

  Drugs 20030101

• Phosphonomethoxyalkyl analogs of nucleotides.

  Current pharmaceutical design 20030101

• [Treatment of viral hepatitis].

  Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20030101

• Viral breakthrough during lamivudine therapy for chronic hepatitis B.

  Intervirology 20030101

• Antivirals for the treatment of chronic hepatitis B: current and future options.

  Intervirology 20030101

• Adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B: a review of the major clinical studies.

  Journal of hepatology 20030101

• Combination therapy for chronic hepatitis B.

  Journal of hepatology 20030101

• Treatment of HBeAg negative chronic hepatitis B with new drugs (adefovir and others).

  Journal of hepatology 20030101

• Management of the patient with hepatitis B virus-related cirrhosis.

  Journal of hepatology 20030101

• Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus.

  Journal of hepatology 20030101

• Controversies about the treatment of hepatitis B (lamivudine, interferon, a combination or more?).

  Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20030101

• Current therapies for chronic hepatitis B.

  Annals of hepatology 20030101

• Adefovir (Hepsera) for chronic hepatitis B infection.

  The Medical letter on drugs and therapeutics 20021209

• Antiviral therapy for hepatitis B virus infections: new targets and technical challenges.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20021201

• Fanconi syndrome and renal failure induced by tenofovir: a first case report.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20021201

• Management of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B.

  Journal of gastroenterology and hepatology 20021201

• Combination and newer therapies for chronic hepatitis B.

  Journal of gastroenterology and hepatology 20021201

• Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity.

  The American journal of the medical sciences 20021201

• [Treatment of hepatitis B].

  La Revue de medecine interne 20021201

• From the Food and Drug Administration.

  JAMA 20021106

• FDA notifications. New treatment approved for chronic hepatitis B.

  AIDS alert 20021101

• Therapy of chronic hepatitis B: current challenges and opportunities.

  Journal of viral hepatitis 20021101

• [Role of interferons in the treatment of hepatitis B and hepatitis C virus infections].

  La Revue de medecine interne 20021101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20021101

• Once-daily quadruple-drug therapy with adefovir dipivoxil, Lamivudine, Didanosine, and efavirenz in treatment-naive human immunodeficiency virus type 1-infected patients.

  The Journal of infectious diseases 20021001

• Hepatitis B: progress in the last 15 years.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20021001

• Prevention of recurrent hepatitis B post-liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20021001

• Treatment of recurrent hepatitis B infection in liver transplant recipients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20021001

• FDA recommends hepatitis B drug.

  AIDS patient care and STDs 20021001

• A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial.

  HIV medicine 20021001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20021001

• [Treatment of chronic hepatitis C in patients coinfected with HIV-HCV/HBV].

  Revista de gastroenterologia de Mexico 20021001

• Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359.

  The Journal of infectious diseases 20020901

• Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine.

  The Journal of antimicrobial chemotherapy 20020901

• Management of chronic viral hepatitis before and after renal transplantation.

  Transplantation 20020827

• Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks.

  Hepatology (Baltimore, Md.) 20020801

• Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavir.

  Clinical pharmacology and therapeutics 20020801

• Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.

  JAMA 20020710

• Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus.

  Antiviral research 20020701

• Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.

  The American journal of gastroenterology 20020701

• Chronic hepatitis B: current and future treatment options.

  Pharmacotherapy 20020601

• Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapy.

  Journal of medical virology 20020501

• [Liver transplantation for patients with hepatitis B/C virus cirrhosis or hepato cellular carcinoma].

  Nihon Geka Gakkai zasshi 20020501

• Adefovir nephrotoxicity and mitochondrial DNA depletion.

  Human pathology 20020501

• Management of patients with chronic hepatitis B.

  Journal of gastroenterology and hepatology 20020401

• Treatment of chronic hepatitis B: case selection and duration of therapy.

  Journal of gastroenterology and hepatology 20020401

• Highlights in the development of new antiviral agents.

  Mini reviews in medicinal chemistry 20020401

• Treatment of hepatitis B and C following liver transplantation.

  Current gastroenterology reports 20020201

• How will we use the new antiviral agents for hepatitis B?

  Current gastroenterology reports 20020201

• Evolving therapies for the treatment of chronic hepatitis B virus infection.

  Expert opinion on investigational drugs 20020201

• [New management strategies for hepatitis B].

  Gastroenterologie clinique et biologique 20020201

• Management of viral hepatitis B.

  Journal of gastroenterology and hepatology 20020201

• Raman spectroscopy study of acid-base and structural properties of 9-[2-(phosphonomethoxy)ethyl]adenine in aqueous solutions.

  Biopolymers 20020101

• Drug treatment of pediatric chronic hepatitis B.

  Paediatric drugs 20020101

• Adefovir dipivoxil. Bis-POM PMEA, GS 0840, GS 840, Piv2PMEA.

  Drugs in R&D 20020101

• Update on the management of chronic hepatitis B.

  Reviews in gastroenterological disorders 20020101

• Assessing hepatitis B virus resistance in vitro and molecular mechanisms of nucleoside resistance.

  Seminars in liver disease 20020101

• Advances in therapy for chronic hepatitis B.

  Seminars in liver disease 20020101

• New treatment approved for chronic hepatitis B.

  FDA consumer 20020101

• Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir.

  Gut 20011201

• Nucleoside analogues for chronic hepatitis B.

  European journal of gastroenterology & hepatology 20011201

• Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule.

  The Journal of pharmacology and experimental therapeutics 20011101

• Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs.

  Cancer research 20011101

• Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20011101

• Therapeutic management of hepatitis B-related cirrhosis.

  Journal of viral hepatitis 20011101

• Treatment of chronic hepatitis B.

  The Lancet. Infectious diseases 20011101

• HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study.

  AIDS (London, England) 20010928

• The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial.

  AIDS (London, England) 20010907

• Carrier-mediated delivery improves the efficacy of 9-(2-phosphonylmethoxyethyl)adenine against hepatitis B virus.

  Molecular pharmacology 20010901

• Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus.

  Gut 20010901

• Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study.

  Lancet (London, England) 20010901

• Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: genotypic and phenotypic analyses of study GS-96-408.

  Journal of acquired immune deficiency syndromes (1999) 20010815

• Tenofovir, adefovir, and zidovudine susceptibilities of primary human immunodeficiency virus type 1 isolates with non-B subtypes or nucleoside resistance.

  AIDS research and human retroviruses 20010810

• Antiviral drugs: current state of the art.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20010801

• Update on chronic viral hepatitis.

  Postgraduate medical journal 20010801

• Current pharmacotherapy for hepatitis B infection.

  Expert opinion on pharmacotherapy 20010801

• Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion.

  Human pathology 20010701

• Therapy of chronic hepatitis B and C and treatment options in HCV-HIV co-infection--European Conference on Infectious Diseases and Tropical Medicine, EuCID 2001, 3-6 May 2001, Leipzig.

  European journal of medical research 20010628

• Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus.

  The Journal of antimicrobial chemotherapy 20010601

• Hepatitis B virus infection: resistance to antiviral agents.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20010601

• Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication.

  Antiviral therapy 20010601

• Formation of ternary complexes by coordination of (diethylenetriamine)-platinum(II) to N1 or N7 of the adenine moiety of the antiviral nucleotide analogue 9.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20010504

• Hepatitis B infection in China.

  Clinics in liver disease 20010501

• Viral hepatitis.

  Current opinion in gastroenterology 20010501

• Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA.

  Bioorganic & medicinal chemistry letters 20010423

• [Current knowledge on chronic hepatitis B therapy].

  Gastroenterologie clinique et biologique 20010401

• Efficiency comparisons of rank and permutation tests based on summary statistics computed from repeated measures data.

  Statistics in medicine 20010315

• AACR/NHRI Joint Conference: hepatitis and hepatocellular carcinoma: novel approaches.

  IDrugs : the investigational drugs journal 20010301

• The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance.

  The Journal of clinical investigation 20010215

• Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis.

  Annals of surgery 20010201

• [Current treatment of hepatitis B].

  Gastroenterologia y hepatologia 20010201

• Drug therapy for hepatitis B.

  Advances in internal medicine 20010101

• Duck hepatitis B virus polymerase gene mutants associated with resistance to lamivudine have a decreased replication capacity in vitro and in vivo.

  Journal of hepatology 20010101

• Preliver transplant viremic status and the choice of anti-HBV regimens.

  Transplantation proceedings 20010101

• Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.

  Antiviral chemistry & chemotherapy 20010101

• Drug discovery and development of antiviral agents for the treatment of chronic hepatitis B virus infection.

  Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques 20010101

• Kinetic studies of the degradation of oxycarbonyloxymethyl prodrug of Adefovir and Tenofovir in solution.

  Nucleosides, nucleotides & nucleic acids 20010101

• Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH-sensitive liposomes.

  Nucleosides, nucleotides & nucleic acids 20010101

• Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs.

  Nucleosides, nucleotides & nucleic acids 20010101

• Low-dose adefovir for the treatment of chronic hepatitis B in HIV-infected people.

  GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies 20010101

• Hepatitis B: therapeutic perspectives.

  Forum (Genoa, Italy) 20010101

• [Hepatitis B in children: natural history and therapy].

  Bulletin et memoires de l'Academie royale de medecine de Belgique 20010101

• Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants.

  Hepatology (Baltimore, Md.) 20000701

• Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin.

  Transplantation 19991227

• Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro.

  The Journal of infectious diseases 19990101

• Human immunodeficiency virus type 1 reverse transcriptase expressing the K70E mutation exhibits a decrease in specific activity and processivity.

  Molecular pharmacology 19980801

• Four new antiretroviral medications will soon offer more options to HIV patients.

  Faculty notes (New Orleans, La.) 19980101

• Antiviral drug susceptibility of human herpesvirus 8.

  Antimicrobial agents and chemotherapy 19971201

• Inhibition of murine macrophage nitric oxide synthase expression by a pivoxil prodrug of antiviral acyclic nucleotide analogue 9-(2-phosphonomethoxyethyl)adenine.

  Biochemical pharmacology 19971015

• Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability.

  Journal of medicinal chemistry 19961206

• Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine.

  Antimicrobial agents and chemotherapy 19960101

• Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.

  Antiviral research 19951201

• Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).

  Journal of medicinal chemistry 19940610

• Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates.

  Antimicrobial agents and chemotherapy 19931001

• Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine.

  Antiviral research 19920901